{
  "meta": {
    "title": "221_Medicine_Neet_2022",
    "url": "https://brainandscalpel.vercel.app/221-medicine-neet-2022-017e027b.html",
    "scrapedAt": "2025-11-30T12:57:06.321Z"
  },
  "questions": [
    {
      "text": "A patient with diabetes mellitus for the past 5 years presents with vomiting and abdominal pain. She is non-compliant with medication and appears dehydrated. Investigations revealed a blood sugar value of 500 mg/dL and the presence of ketone bodies. What is the next best step in management?",
      "choices": [
        {
          "id": 1,
          "text": "Intravenous fluids with long acting insulin"
        },
        {
          "id": 2,
          "text": "Intravenous fluids"
        },
        {
          "id": 3,
          "text": "Intravenous insulin"
        },
        {
          "id": 4,
          "text": "Intravenous fluids with regular insulin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical vignette points to a diagnosis of <strong>diabetic ketoacidosis</strong> (DKA) for which the next best step in management would be <strong>intravenous fluids with regular insulin</strong>.</p>\n<p>DKA is a complication of diabetes mellitus that arises due to relative or absolute <strong>insulin deficiency,</strong> seen more commonly in patients with diabetes mellitus type 1.&nbsp;Clinical features include nausea, <strong>vomiting</strong>, <strong>abdominal pain</strong>, and tachycardia. Hyperglycemia leads to volume depletion and subsequent hypotension.<strong> Kussmaul respiration</strong> and <strong>fruity odor</strong> on the breath are characteristic of the condition.</p>\n<p>Investigation shows&nbsp;<strong>elevated glucose levels</strong> (250-600 mg/dL), <strong>ketonemia</strong>, and <strong>metabolic acidosis</strong> with a<strong> high anion gap</strong>.&nbsp;</p>\n<p>Patients with DKA are also at an increased risk of developing<strong> rhinocerebral mucormycosis</strong>. Coma and <strong>cerebral edema</strong> are extremely serious complications that can arise.</p>\n<p>Once the diagnosis is confirmed <strong>intravenous fluids</strong> should be given along with a <strong>bolus</strong> of short-acting regular insulin. Then, intravenous administration of 0.1 units/kg/hour of regular insulin is administered until acidosis resolves and the patient is stable.</p>\n<p>Insulin treatment and resolution of acidosis can lead to <strong>potassium store depletion</strong><strong>&nbsp;</strong>in DKA but it might be normal or slightly elevated at presentation. This is secondary to acidosis and volume depletion. If the initial potassium level is &lt;3.3 meq/L, insulin should not be administered till it is corrected.&nbsp;</p>\n<p>Other options:</p>\n<p>Option A:<strong> Long-acting insulin</strong> is started only when the patient resumes eating.&nbsp;</p>\n<p>Option B: Intravenous insulin (bolus) is one of the initial steps along with intravenous fluids.</p>\n<p>Option C: Intravenous fluids are given as the first step in management. A bolus of intravenous insulin is also required.&nbsp;</p><hr><h3>Related Pearl: Comparative Features of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>DKA</strong></p>\n</td>\n<td>\n<p><strong>HHS</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Seen in </strong></p>\n</td>\n<td>\n<p>Type 1 DM</p>\n</td>\n<td>\n<p>Type 2 DM</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Clinical features</strong></p>\n</td>\n<td>\n<p>Abdominal pain</p>\n<p>Kussmaul respiration</p>\n<p>Fruity odour of breath</p>\n</td>\n<td>\n<p>Altered sensorium</p>\n<p>Coma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glucose (mg/dL)</strong></p>\n</td>\n<td>\n<p>250&ndash;600</p>\n</td>\n<td>\n<p>600&ndash;1200</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sodium</strong></p>\n</td>\n<td>\n<p>120&ndash;125</p>\n</td>\n<td>\n<p>135&ndash;145</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Osmolality </strong></p>\n</td>\n<td>\n<p>300&ndash;320</p>\n</td>\n<td>\n<p>330&ndash;380</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Plasma Ketones</strong></p>\n</td>\n<td>\n<p>++++</p>\n</td>\n<td>\n<p>+/-</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum Bicarbonate</strong></p>\n</td>\n<td>\n<p>&lt; 15 meq/ L</p>\n</td>\n<td>\n<p>Normal to slightly &darr;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pH </strong></p>\n</td>\n<td>\n<p>6.8&ndash;7.3</p>\n</td>\n<td>\n<p>&gt;7.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Arterial pCO<sub>2 </sub>(mmHg)</strong></p>\n</td>\n<td>\n<p>20&ndash;30</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anion Gap</strong></p>\n</td>\n<td>\n<p><strong>&uarr;</strong></p>\n</td>\n<td>\n<p>Normal to slightly &uarr;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Comparative Features of Type I and Type II Diabetes mellitus</h3><table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n</td>\n<td>\n<p><strong>Type 1 DM</strong></p>\n</td>\n<td>\n<p><strong>Type 2 DM</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Etiology</strong></p>\n</td>\n<td>\n<p>Autoimmune</p>\n</td>\n<td>\n<p>Insulin resistance which later leads to impaired insulin secretion</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Age at onset</strong></p>\n</td>\n<td>\n<p>Usually young children</p>\n</td>\n<td>\n<p>Adult</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>HLA association</strong></p>\n</td>\n<td>\n<p><strong>DR3, DR4</strong></p>\n</td>\n<td>\n<p>No HLA association</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Body weight</strong></p>\n</td>\n<td>\n<p>Normal / Underweight</p>\n</td>\n<td>\n<p><strong>Obese</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Family history</strong></p>\n</td>\n<td>\n<p>May or may not be positive</p>\n</td>\n<td>\n<p>Usually<strong> strongly positive</strong>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Presentation</strong></p>\n</td>\n<td>\n<p>Abrupt</p>\n</td>\n<td>\n<p>Gradual or symptomatic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Insulin requirement</strong></p>\n</td>\n<td>\n<p>Absolute</p>\n</td>\n<td>\n<p>Oral hypoglycemics, later insulin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Serum insulin level / C peptide level</strong></p>\n</td>\n<td>\n<p>Low</p>\n</td>\n<td>\n<p>High</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n<p><strong>Clinical Features</strong></p>\n</td>\n<td>\n<p><strong>Diabetic ketoacidosis</strong> is common&nbsp;</p>\n<p>It is associated with other autoimmune diseases like:</p>\n<p><strong>Thyroid disorders</strong></p>\n<ul>\n<li>Addison's disease</li>\n<li>Rheumatoid arthritis</li>\n<li>Schmidt syndrome/ Polyglandular failure syndrome</li>\n</ul>\n</td>\n<td>\n<p><strong>Non-ketotic hyperosmolar coma</strong> is common</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Causes of Metabolic Acidosis</h3><table>\n<tbody>\n<tr>\n<td>High Anion-Gap Metabolic Acidosis (MUDPILES)</td>\n<td>Normal Anion-Gap Metabolic Acidosis (FUSED CAR)</td>\n</tr>\n<tr>\n<td><strong>M</strong>ethanol</td>\n<td><strong>F</strong>istula pancreatic</td>\n</tr>\n<tr>\n<td><strong>U</strong>remia (Renal failure - Acute or Chronic)</td>\n<td><strong>U</strong>reterosigmoidostomy</td>\n</tr>\n<tr>\n<td><strong>D</strong>iabetic ketoacidosis</td>\n<td><strong>S</strong>mall bowel fistula</td>\n</tr>\n<tr>\n<td><strong>P</strong>araldehyde</td>\n<td><strong>E</strong>xtra chloride (Hyperalimentation)</td>\n</tr>\n<tr>\n<td><strong>I</strong>ron tablets, INH</td>\n<td><strong>D</strong>iarrhea</td>\n</tr>\n<tr>\n<td><strong>L</strong>actic acidosis</td>\n<td><strong>C</strong>arbonic anhydrase inhibitor (acetazolamide)</td>\n</tr>\n<tr>\n<td><strong>E</strong>thylene glycol</td>\n<td><strong>A</strong>ddison's disease</td>\n</tr>\n<tr>\n<td><strong>S</strong>alicylates</td>\n<td><strong>R</strong>enal tubular acidosis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5391",
      "difficulty": "easy"
    },
    {
      "text": "The cerebrospinal fluid (CSF) specimen of a patient is shown below along with the microscopy. The report shows mononuclear cytosis, elevated proteins, and low sugars. Which of the following is the likely etiology?",
      "choices": [
        {
          "id": 1,
          "text": "Tuberculous meningitis"
        },
        {
          "id": 2,
          "text": "Aseptic meningitis"
        },
        {
          "id": 3,
          "text": "Bacterial meningitis"
        },
        {
          "id": 4,
          "text": "Chemical meningitis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario along with the cerebrospinal fluid (CSF) sample with <strong>cobweb-like clot</strong> and slide showing <strong>lymphocytic predominance</strong> points to a diagnosis of<strong> tubercular meningitis</strong>.&nbsp;</p>\n<p>Tuberculous meningitis caused by <em><strong>Mycobacterium tuberculosis</strong></em> is caused by the formation of <strong>tubercles</strong> in the brain parenchyma. This happens during the hematogenous spread of the bacilli during primary infection. It can also be due to the rupture of a subependymal tubercle into the subarachnoid space.</p>\n<p>Tuberculous meningitis presents as a <strong>subacute infection</strong> and has a longer course than bacterial meningitis. <strong>Ocular nerve palsy</strong> is a common association as there is marked meningeal involvement at the base of the brain. The patient can also develop hydrocephalus.</p>\n<p>The CSF sample shows a pellicle or <strong>cobweb-like clots</strong>. <strong>Acid-fast bacilli</strong> can be best isolated from these. There is usually <strong>lymphocytic leukocytosis</strong>, <strong>low glucose </strong>concentration, and <strong>elevated proteins</strong>. CSF culture remains the gold standard for diagnosis.&nbsp;</p>\n<p>The clinical triad of <strong>fever</strong>, <strong>headache</strong>, and<strong> nuchal rigidity</strong> is common to all types of meningitis. Nuchal rigidity is the resistance of the neck to passive flexion and is pathognomonic of meningeal irritation. <strong>Kernig's</strong> and <strong>Brudzinski's</strong> signs are other features of meningeal irritation. <strong>Raised intracranial pressure</strong> (ICP) is a complication that presents as<strong> papilledema</strong>, disorientation, or dilated poorly reactive pupils.</p>\n<p>Other options:</p>\n<p>Option B - <strong>Aseptic meningitis</strong> is commonly caused by <strong>enteroviruses</strong> such as coxsackieviruses, and varicella-zoster virus. It is more benign and usually self-limiting compared to pyogenic meningitis. Gram's staining of the CSF sample shows lymphocytosis but&nbsp;<strong>not</strong>&nbsp;the organism.</p>\n<p>Option C - <strong>Bacterial meningitis</strong> is most commonly caused by <em><strong>Streptococcus pneumoniae</strong></em> and <em>Neisseria meningitidis</em>. <strong>Blood culture</strong> can be used for diagnosis. CSF findings are described in the pearl below.&nbsp;<strong>Antibiotic prophylaxis</strong>&nbsp;is provided to the&nbsp;<strong>close contacts</strong>&nbsp;of persons with confirmed <strong>meningococcal</strong> disease.</p>\n<p>Option D - <strong>Chemical meningitis</strong> is a common cause of <strong>chronic</strong> meningitis. It can arise due to the rupture of tumor contents from a <strong>cystic glioma</strong>, dermoid cyst, or craniopharyngioma into the CSF.</p><hr><h3>Related Pearl: CSF findings in meningitis</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Glucose&nbsp;</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>Protein</strong><br /><strong>(mg/dL)</strong></td>\n<td><strong>WBC (per&nbsp;&mu;L)</strong></td>\n</tr>\n<tr>\n<td><strong>Normal</strong></td>\n<td>40-85</td>\n<td>15-45</td>\n<td>\n<p>&lt;5</p>\n<p>60-70% lymphocytes, &le;30% monocytes / macrophages</p>\n</td>\n</tr>\n<tr>\n<td><strong>Bacterial</strong></td>\n<td>&lt;40</td>\n<td>&gt;100</td>\n<td>\n<p>&gt;1000</p>\n<p>&uarr;&uarr;PMNs (&ge;80%)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Viral</strong></td>\n<td>Normal</td>\n<td>20-80</td>\n<td>\n<p>25-500</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Tuberculous</strong></td>\n<td>&lt;50 <br />in 75% cases</td>\n<td>100-200</td>\n<td>\n<p>25-100</p>\n<p>Predominantly lymphocytes</p>\n</td>\n</tr>\n<tr>\n<td><strong>Fungal</strong></td>\n<td>&darr; to normal</td>\n<td>150-300</td>\n<td>\n<p>40-600</p>\n<p>Lymphocytes or PMNs, depending on specific organism</p>\n</td>\n</tr>\n<tr>\n<td><strong>Parasitic</strong></td>\n<td>Normal</td>\n<td>50-200&nbsp;</td>\n<td>\n<p>150-2000</p>\n<p>&uarr;&uarr; Eosinophils (&ge;50%)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Acute bacterial meningitis - causes and empirical treatment</h3><table>\n<tbody>\n<tr>\n<td><strong>Patient Group</strong></td>\n<td><strong>Bacterial Pathogen</strong></td>\n<td><strong>Empirical Therapy</strong></td>\n</tr>\n<tr>\n<td>Age&lt;1 month</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p>Enterobacteriacea</p>\n<p><em>Listeria monocytogenes</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br />Ampicillin</td>\n</tr>\n<tr>\n<td>1 month - 2 years</td>\n<td>\n<p><em>E. coli</em></p>\n<p>Group B Streptococci</p>\n<p><em>H. influenza</em></p>\n<p><em>S. pneumonia</em></p>\n<p><em>N. meningitidis</em></p>\n</td>\n<td>3rd generation Cephalosporin+<br />Ampicillin+<br />Vancomycin (if PRSP suspected)</td>\n</tr>\n<tr>\n<td>2 - 50 years and no risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br /><em>N. meningitidis</em><br /><br /></td>\n<td>\n<p>3rd generation cephalosporin+<br />Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Age &gt; 50 yrs and/or risk factors for Listeria</td>\n<td><em>S. pneumoniae</em><br /><em>N. meningitidis</em><br /><em>L. monocytogenes</em><br />Group B Streptococci</td>\n<td>\n<p>3rd generation cephalosporin+<br />Vancomycin+<br />Ampicillin</p>\n</td>\n</tr>\n<tr>\n<td>Post-craniotomy/Head trauma/CSF Rhinorrhea</td>\n<td>Gram negative bacilli</td>\n<td>\n<p>Ceftazidime+<br />Vancomycin</p>\n</td>\n</tr>\n<tr>\n<td>Post-shunt surgery/ Ommaya reservoir</td>\n<td>\n<p><em>S. aureus</em><br />Coagulase-negative staphylococci</p>\n</td>\n<td>Ceftazidime+<br />Vancomycin</td>\n</tr>\n<tr>\n<td>Immunocompromised state </td>\n<td>\n<p><em> S. pneumoniae                    </em></p>\n<p><em>N. meningitidis                    </em></p>\n<p><em>L. monocytogenes       </em></p>\n<p>Gram negative bacilli </p>\n</td>\n<td>\n<p>Vancomycin+                      Ampicillin+                         Cefepime                           </p>\n<p>                   OR </p>\n<p>Vancomycin+                      Meropenem      </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*PRSP= penicillin-resistant S pneumoniae </p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/dafb9bf2283b45b59a0a7914f2e03006.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5376",
      "difficulty": "easy"
    },
    {
      "text": "A patient diagnosed to be retro-positive was started on highly active antiretroviral therapy (HAART). Which of the following can be used to monitor treatment efficacy?",
      "choices": [
        {
          "id": 1,
          "text": "CD4+ T cell  count"
        },
        {
          "id": 2,
          "text": "Viral load"
        },
        {
          "id": 3,
          "text": "p24 antigen"
        },
        {
          "id": 4,
          "text": "Viral serotype"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>viral load</strong> can be assessed in a <strong>retro-positive patient</strong> started on <strong>highly active antiretroviral therapy</strong> (HAART) to <strong>monitor</strong> <strong>treatment efficacy</strong>.&nbsp;</p>\n<p>HAART or combination antiretroviral therapy is the mainstay in the management of retro positive patients. It is initiated soon after diagnosis except in cases of cryptococcal or tuberculous meningitis.&nbsp;</p>\n<p>After initiation of therapy, a<strong> ten-fold reduction</strong> in plasma human immunodeficiency virus (HIV) RNA levels in <strong>1-2 months</strong> can be expected. Within six months, a slower decline to &lt;50 copies/mL is anticipated. During the first month of therapy, a <strong>rise </strong>in<strong> CD4+ T cell count</strong> is also predicted. Out of these two parameters, viral load is the better choice to monitor treatment efficacy as it is more<strong> cost-effective</strong>.&nbsp;</p>\n<p><strong>Plasma HIV RNA levels</strong> signify the <strong>rate</strong> of<strong> CD4+ T-cell destruction</strong> and the magnitude of <strong>HIV replication</strong>. It should be monitored within 2-4 weeks of initiation of therapy and after any change in the treatment regimen. It should be repeated every 4-8 weeks till the RNA levels drop to &lt;200 copies/mL and then every 3-6 months subsequently.&nbsp;</p>\n<p>The indications for change in the treatment regimen are:</p>\n<ul>\n<li>&lt; 10-fold drop in HIV RNA levels within 4 weeks of initiation</li>\n<li>&ge; 3-fold increase from the nadir of plasma HIV RNA level not attributable to other causes</li>\n<li>Persistent decline in CD4+ T-cell counts</li>\n<li>Adverse effects</li>\n<li>Clinical deterioration</li>\n</ul>\n<p>Other options:</p>\n<p>Option C: <strong>p24 antigen</strong> is a core protein present in the capsid of the virus.</p>\n<p>Option D: <strong>Viral serotype</strong> does not play a role in monitoring treatment efficacy. Most cases of HIV are due to HIV-1. HIV-2, another human immunodeficiency virus can also cause disease in humans.&nbsp;</p><hr><h3>Related Pearl: NACO ART Guidelines- 2021</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">ART regimen</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">First-line for:</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Tenofovir + Lamivudine + Dolutegravir</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li>All PLHIV who are<strong> age &gt;10 years and body weight &gt;30 kg&nbsp;</strong>with <strong>HIV-1, HIV-2, HIV 1&amp;2 co-infection</strong>&nbsp;who have not received any ART&nbsp;</li>\n<li aria-level=\"1\">Those with <strong>HIV-TB and HIV hepatitis co-infections</strong></li>\n<li aria-level=\"1\"><strong>Pregnant women</strong>, pregnant women presenting in <strong>active labour</strong> and <strong>breastfeeding women</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Abacavir + Lamivudine + Efavirenz</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li aria-level=\"1\">All PLHIV with <strong>abnormal serum creatinine</strong> values&nbsp;</li>\n<li aria-level=\"1\">All PLHIV with <strong>bodyweight less &lt;30 kg</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Tenofovir + Lamivudine + Efavirenz /Lopinavir /Ritonavir</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<ul>\n<li>Women of childbearing age group who do not wish to take Dolutegravir</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li class=\"p1\">All PLHIV who were on the previous recommended regime&nbsp;(Tenofovir+Lamivudine+Efavirenz) to be counselled to switch to new regime. Continue older regime if response is good</li>\n<li class=\"p1\">Women in child-bearing age group to be counselled about Dolutegravir with opt-out option before switching to new regime</li>\n</ul>\n<p>*PLHIV: People living with HIV</p><hr><h3>Related Pearl: WHO clinical staging of HIV</h3><table>\n<tbody>\n<tr>\n<td><strong>Selected conditions &amp; respective clinical stages in HIV &nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Clinical stage 1</strong>\n<ul>\n<li>Asymptomatic</li>\n<li>Persistent generalized lymphadenopathy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Clinical stage 2 (Mild Symptoms)</strong>\n<ul>\n<li>Moderate unexplained weight loss (&lt;10% ofpresumed or measured body weight)&nbsp;</li>\n<li>Recurrent respiratory tract infections (sinusitis,tonsillitis, otitis media, pharyngitis)&nbsp;</li>\n<li>Herpes zoster&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Angular cheilitis&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Recurrent oral ulceration&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Papular pruritic eruption&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Fungal nail infections&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Seborrhoeic dermatitis&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Unexplained persistent hepatosplenomegaly*&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Extensive wart virus infection*&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Extensive molluscum contagiosum*&nbsp; &nbsp; &nbsp; &nbsp;</li>\n<li>Unexplained persistent parotid enlargement*</li>\n</ul>\n<p>&nbsp;*In Children</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Clinical stage 3 &amp; 4 represent Advanced &amp; Severe illness respectively</strong></p>\n<p>For complete staging, please refer WHO guidelines.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: WHO 2018 guidelines for post exposure prophylaxis regimen in HIV</h3><div class=\"page\" title=\"Page 39\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>An HIV post-exposure prophylaxis regimen with two ARV drugs is effective, but three drugs are preferred.</p>\n<p>The recent MOHFW January 2020 guidelines on the management of PEP in HIV recommends the replacement of 2 drug regimen with 3 drug regimen referring to WHO December 2018 guidelines on PEP management protocol in HIV. This shift towards recommending a three-drug regimen for<br />everyone was based on the availability of less toxic and better-tolerated medications.</p>\n<div class=\"page\" title=\"Page 39\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>ADULTS AND ADOLESCENTS:-</strong></p>\n<p>Preferred backbone regimen -&nbsp;TDF + 3TC (or FTC)</p>\n<p>New drug - &nbsp;DTG is the preferred third drug for HIV post-exposure prophylaxis</p>\n<p>New drug -&nbsp;<span>ATV/r, DRV/r, LPV/r and RAL may be considered as alternative third drug options for post-exposure prophylaxis</span></p>\n<p><strong>CHILDREN:-</strong></p>\n<div class=\"page\" title=\"Page 39\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Preferred backbone regimen -&nbsp;AZT + 3TC</p>\n<div class=\"page\" title=\"Page 39\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ABC + 3TC or TDF + 3TC (or FTC) can be considered as alternative regimens</p>\n<p>New drug -&nbsp;DTG is the preferred third drug for HIV post-exposure prophylaxis</p>\n<p>New drug -&nbsp;<span>ATV/r, DRV/r, LPV/r and RAL may be considered as alternative third drug options for post-exposure prophylaxis</span></p>\n<p>&nbsp;</p>\n<p><span>Legend</span></p>\n<p><span>TDF - Tenofovir disoproxil fumarate&nbsp;</span></p>\n<p>3TC - Lamivudine&nbsp;</p>\n<p>FTC - Emtricitabine&nbsp;</p>\n<p>DTG - Dolutegravir&nbsp;</p>\n<p>ATV/r - Atazanavir + ritonavir&nbsp;</p>\n<p>DRV/r - Darunavir + ritonavir&nbsp;</p>\n<p>LPV/r - Lopinavir + ritonavir&nbsp;</p>\n<p>RAL - Raltegravir&nbsp;</p>\n<p>AZT - Zidovudine&nbsp;</p>\n<p>ABC - Abacavir&nbsp;</p>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 39\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p>&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5472",
      "difficulty": "medium"
    },
    {
      "text": "A female patient presents to you with a unilateral headache. It is associated with nausea, photophobia, and phonophobia. What is the drug of choice for acute management?",
      "choices": [
        {
          "id": 1,
          "text": "Flunarizine"
        },
        {
          "id": 2,
          "text": "Sumatriptan"
        },
        {
          "id": 3,
          "text": "Propranolol"
        },
        {
          "id": 4,
          "text": "Topiramate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical vignette is suggestive of an <strong>acute attack</strong> of <strong>migraine</strong>&nbsp;and the drug of choice for acute management is&nbsp;<strong>sumatriptan</strong>.</p>\n<p>Migraine is the second most common cause of headaches and is seen more commonly in <strong>women</strong>. It presents as an <strong>episodic headache</strong> associated with <strong>nausea</strong>, vomiting, <strong>photosensitivity</strong>, and <strong>sensitivity to sound </strong>(phonophobia). Common<strong> triggers</strong> include bright lights, sounds, and hunger.&nbsp;</p>\n<p>The release of vasoactive peptides such as <strong>calcitonin gene-related peptide</strong> (CGRP) by the trigeminal nucleus cells is the theory used to explain the pathogenesis of the condition. The neurotransmitters <strong>serotonin</strong> and <strong>dopamine</strong> also play a part.</p>\n<p><strong>Triptans</strong> are <strong>5-HT1B</strong> and <strong>5-HT1D receptor agonists</strong> and they act by arresting the nociceptive nerve signaling in the trigeminovascular system. In addition, they cause <strong>cranial vasoconstriction</strong>. Cardiac side effects such as transient myocardial ischemia, coronary artery vasospasm, and <strong>myocardial infarction</strong> can occur in patients with risk factors for coronary artery disease. Other side effects include sweating, nausea, and <strong>serotonin syndrome</strong> when used in combination with selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs).</p>\n<p><strong>Ergotamine</strong>, an ergot alkaloid are serotonin receptor agonists which can be used to treat an acute attack. They produce <strong>long-lasting vasoconstriction</strong> and can result in <strong>gangrene</strong> of fingers and toes (ergotism). These drugs are contraindicated in sepsis, ischemic heart disease, and <strong>peripheral vascular disease</strong>.&nbsp;</p>\n<p>Migraine can broadly be classified into:</p>\n<ul>\n<li>Migraine with aura</li>\n<li>Migraine without aura</li>\n<li>Chronic migraine</li>\n</ul>\n<p>The migraine disability assessment score (MIDAS) can be used to assess the severity of the condition. <strong>Avoidance</strong> of recognized triggers is helpful to avoid symptoms. The various drugs used to treat an acute attack of migraine are non-steroidal anti-inflammatory drugs (NSAIDs), triptans, gepants (rimegepant), ditans (lasmiditan), and <strong>dopamine receptor antagonists</strong> (domperidone).&nbsp;</p>\n<p>In patients with&nbsp;<strong>&ge;4 attacks </strong>in a<strong> month</strong>, <strong>prophylactic</strong> medications can be used. The various FDA-approved drugs include <strong>propranolol</strong>, timolol, <strong>flunarizine</strong>, and <strong>topiramate</strong>.</p>\n<p>Other options:&nbsp;</p>\n<p>Option A - Flunarizine is a <strong>calcium channel blocker</strong> that can be used in migraine prophylaxis. Side effects include weight gain, depression, and parkinsonism.&nbsp;</p>\n<p>Option C - Propranolol is a <strong>non-selective&nbsp;&beta;-receptor antagonist</strong> that can be used to treat hypertension, <strong>arrhythmias</strong>, and migraine prophylaxis. It is contraindicated in patients with chronic obstructive pulmonary disease (COPD) as it can cause <strong>bronchoconstriction</strong>. Side effects include fatigue, depression, and insomnia.</p>\n<p>Option D - Topiramate is an FDA-approved drug for generalized tonic-clonic seizures, <strong>Lennox-Gastaut syndrome</strong>, and for migraine prophylaxis in adults. Adverse effects include somnolence, weight loss, and nervousness.</p><hr><h3>Related Pearl: Simplified diagnostic criteria for migraine</h3><p>Repeated attacks of headache lasting 4-72 h in patients with a normal physical examination with no other reasonable cause for the headache, and</p>\n<p><strong>At least 2 of the following features:</strong></p>\n<ul>\n<li>Unilateral pain</li>\n<li>Throbbing pain</li>\n<li>Aggravation by movement</li>\n<li>Moderate or severe intensity</li>\n</ul>\n<p><strong>Plus at least 1 of the following features:</strong></p>\n<ul>\n<li>Nausea/vomiting</li>\n<li>Photophobia and phonophobia</li>\n</ul><hr><h3>Related Pearl: Trigeminal Autonomic Cephalalgia</h3><p><strong>Types of trigeminal autonomic cephalalgia:</strong></p>\n<ul>\n<li>Cluster headache</li>\n<li>Paroxysmal hemicranias</li>\n<li>Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT)</li>\n<li>Short-lasting unilateral neuralgiform&nbsp;<em>headache</em>&nbsp;attacks with cranial autonomic features (SUNA)</li>\n<li>Hemicrania continua</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>&nbsp;Cluster headache</strong></td>\n<td><strong>Paroxysmal hemicrania&nbsp;</strong></td>\n<td><strong>&nbsp;SUNCT/SUNA</strong></td>\n</tr>\n<tr>\n<td>Gender&nbsp;</td>\n<td>Males&gt;females</td>\n<td>Female=Males</td>\n<td>Female=Males</td>\n</tr>\n<tr>\n<td>Character of pain&nbsp;</td>\n<td>Stabbing /boring</td>\n<td>Throbbing pain&nbsp;/stabbing /boring</td>\n<td>Burning /stabbing/sharp</td>\n</tr>\n<tr>\n<td>Severity of pain&nbsp;</td>\n<td>Excruciating&nbsp;</td>\n<td>Excruciating</td>\n<td>Severe to excruciating</td>\n</tr>\n<tr>\n<td>Site of pain&nbsp;</td>\n<td>Orbit, temple</td>\n<td>Orbit, temple</td>\n<td>Periorbital</td>\n</tr>\n<tr>\n<td>Attack frequency&nbsp;</td>\n<td>1-8 /day</td>\n<td>1-20/day</td>\n<td>3-200/day</td>\n</tr>\n<tr>\n<td>Duration</td>\n<td>15min-3 hours</td>\n<td>2-30 min</td>\n<td>5-240seconds</td>\n</tr>\n<tr>\n<td>Migraneous feature&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes&nbsp;</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Alcohol trigger&nbsp;</td>\n<td>Yes</td>\n<td>No</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Cutaneous trigger</td>\n<td>No</td>\n<td>No</td>\n<td>Yes</td>\n</tr>\n<tr>\n<td>Response to indomethacin</td>\n<td>No</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Abortive treatment</td>\n<td>\n<p>100% oxygen</p>\n<p>Sumatriptan injection</p>\n</td>\n<td>\n<p>No effective treatment</p>\n</td>\n<td>\n<p>IV lidocaine&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Prophylaxis</td>\n<td>\n<p>Chronic cluster</p>\n<ul>\n<li>Lithium</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n<p>Episodic cluster&nbsp;</p>\n<ul>\n<li>Steroids&nbsp;</li>\n<li>Verapamil</li>\n<li>Methysergide</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Indomethacin</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n<li>Topiramate</li>\n<li>Gabapentin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Indomethacin</strong> is effective in paroxysmal hemicrania,hemicrania continuum, and primary sexual/ exercise headache</li>\n<li>Cutaneous trigger is also seen in trigeminal neuralgia, however, <strong>trigeminal neuralgia</strong> is a <strong>separate entity </strong>and not a part of trigeminal autonomic cephalalgia&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5363",
      "difficulty": "easy"
    },
    {
      "text": "A hypertensive patient who is non-compliant with medication presents to you with sudden onset breathlessness. A chest X-ray was done, which is shown below. How will you manage this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Intravenous salbutamol"
        },
        {
          "id": 2,
          "text": "Intravenous nitroglycerine"
        },
        {
          "id": 3,
          "text": "Nebulization with salbutamol"
        },
        {
          "id": 4,
          "text": "Oxygen and antibiotics"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical vignette along with the X-ray given points to a diagnosis of <strong>acute cardiogenic pulmonary edema</strong>. It can be managed by the administration of <strong>intravenous nitroglycerin</strong>.</p>\n<p><strong>Acute severe hypertension</strong>, acute myocardial infarction, or <strong>exacerbation</strong> of chronic heart failure are some of the common causes of cardiogenic pulmonary edema. It can be precipitated by the <strong>discontinuation of medications&nbsp;</strong>(non-compliant patient), excessive salt intake, or tachyarrhythmias.&nbsp;</p>\n<p>It presents with <strong>severe dyspnea</strong>, <strong>pink frothy sputum</strong> production, diaphoresis, and cyanosis. Auscultation reveals <strong>rales</strong> and rhonchi in all lung fields. Chest X-ray shows increased <strong>interstitial markings</strong>, <strong>vascular redistribution</strong>, and alveolar edema in a<strong> butterfly</strong>&nbsp;pattern. <strong>Cardiomegaly</strong> might be seen in cases of chronic heart failure.</p>\n<p>Management of pulmonary edema includes the use of <strong>diuretics</strong>, <strong>nitrates</strong>, and <strong>morphine</strong> to decrease the preload. <strong>Nitroglycerin</strong> and isosorbide dinitrate have a <strong>rapid onset</strong> of action and can be given sublingually. If there is persistence of pulmonary edema and no hypotension, it can be administered intravenously.</p>\n<p><strong>Oxygen therapy</strong> to maintain a saturation &gt;92% is recommended. Positive-pressure ventilation through a face mask or endotracheal intubation is required if saturation is not maintained even with supplemental oxygen. A <strong>sitting</strong> <strong>position</strong> with legs hanging by the side of the bed can be used to reduce venous return in patients without hypotension.</p>\n<p>Non-cardiac causes of pulmonary edema are high altitude, sepsis, and disseminated intravascular coagulation.&nbsp;</p>\n<p><strong>Heart failure</strong> is a manifestation of most chronic cardiac conditions such as hypertension, valvular heart disease, and coronary artery disease. Symptoms such as<strong> shortness of breath</strong>, orthopnea, and paroxysmal nocturnal dyspnea point to <strong>left heart failure</strong> due to pulmonary congestion. In contrast, symptoms such as <strong>pedal edema</strong>, weight gain, early satiety, and hepatic congestion are characteristic of <strong>right heart failure</strong>.</p>\n<p>Other options:&nbsp;</p>\n<p>Options A and C -&nbsp; <strong>Salbutamol</strong> is a short-acting<strong> &beta;2-agonist</strong> that is used to treat acute severe asthma. Salbutamol nebulization is used to treat <strong>hyperkalemia</strong>. Side effects include tachycardia, tremors, hypokalemia, and <strong>raised glucose levels</strong>.&nbsp;</p>\n<p>Option D -<strong> Oxygen supplementation</strong> is recommended for pulmonary edema but <strong>antibiotics</strong> have <strong>no role</strong> in cardiogenic pulmonary edema.</p><hr><h3>Related Pearl: Drugs used in heart failure</h3><div>Drugs used in<strong> acute decompensated heart failure:</strong></div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Intravenous vasodilators</strong></td>\n</tr>\n<tr>\n<td>\n<p>Nitroglycerine</p>\n<p>Sodium nitroprusside</p>\n</td>\n<td>Decrease preload and afterload</td>\n</tr>\n<tr>\n<td>Nesiritide</td>\n<td>Recombinant human BNP</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Intravenous positive inotropes</strong></td>\n</tr>\n<tr>\n<td>\n<p>Dobutamine</p>\n<p>Dopamine</p>\n<p>Epinephrine</p>\n<p>Norepinephrine</p>\n</td>\n<td>&beta;1 receptor-mediated stimulation of cardiac output</td>\n</tr>\n<tr>\n<td>\n<p>Enoximone</p>\n<p>Milrinone</p>\n</td>\n<td>PDE 3/4 inhibitors</td>\n</tr>\n<tr>\n<td>\n<p>Levosimendan</p>\n<p>Pimobendan</p>\n</td>\n<td>Combined Ca<sup>2+</sup> sensitizers and PDE3 inhibitors</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div>\n<div>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Drugs used for rapid symptom relief</strong></td>\n</tr>\n<tr>\n<td>\n<p>Bumetanide</p>\n<p>Furosemide</p>\n<p>Torasemide</p>\n</td>\n<td>Loop diuretics- used for symptomatic treatment of severe heart failure and acute decompensation.</td>\n</tr>\n<tr>\n<td>Morphine</td>\n<td>Opioid - to calm the patient and decreases cardiac O2 consumption</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div>\n<div>Drugs used in<strong> chronic heart failure:</strong></div>\n<div>\n<table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td>ACE inhibitors</td>\n<td>Used as first-line therapy</td>\n</tr>\n<tr>\n<td>ARBs</td>\n<td>Used in case of intolerance to ACE inhibitors</td>\n</tr>\n<tr>\n<td>Beta-blockers</td>\n<td>Used as first-line therapy &nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Spironolactone</p>\n<p>Eplerenone</p>\n</td>\n<td>Mineralocorticoid receptor antagonists - first-line drugs for symptomatic heart failure.</td>\n</tr>\n<tr>\n<td>SGLT-2 inhibitors</td>\n<td>Used as 1st line therapy- reduces mortality and morbidity</td>\n</tr>\n<tr>\n<td>Sacubitril/Valsartan</td>\n<td>Neprilysin inhibitor/ARB(ARNI)</td>\n</tr>\n<tr>\n<td>Ivabradine</td>\n<td>Inhibitor of I<sub>f</sub>&nbsp;current in the sinoatrial node</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n<div>&nbsp;</div><hr><h3>Related Pearl: Definitions of Heart Failure According to EF (ESC HF guidelines 2016)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Newer definitions</strong></p>\n</td>\n<td>\n<p><strong>Ejection fraction</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heart failure with reduced Ejection Fraction (HFrEF)</p>\n</td>\n<td>\n<p>&le;40%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Heart failure with preserved Ejection Fraction (HFpEF)</strong></p>\n</td>\n<td>\n<p>&ge;50%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heart failure with midrange Ejection Fraction (HFmrEF)</p>\n</td>\n<td>\n<p>40-49%</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Summary of Pathogenesis of Major Findings in Congestive Heart Failure</h3><p><strong>Summary of Pathogenesis of Major Findings in Congestive Heart Failure</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Abnormality</strong></p>\n</td>\n<td>\n<p><strong>Cause</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Weakness, exercise intolerance, fatigue</p>\n</td>\n<td>\n<p>Left ventricle output inadequate to perfuse muscles; especially, failure of output to rise with exercise</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ankle, sacral edema</p>\n</td>\n<td>\n<p>Increased peripheral venous pressure &rarr;increased fluid transudation.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatomegaly</p>\n</td>\n<td>\n<p>Increased peripheral venous pressure &rarr;increased resistance to portal flow.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pulmonary congestion</p>\n</td>\n<td>\n<p>Increased pulmonary venous pressure &rarr;pulmonary venous distention and transudation of fluid into air spaces</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dyspnea on exertion</p>\n</td>\n<td>\n<p>Failure of left ventricular output to rise during exercise &rarr; increased pulmonary venous pressure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Paroxysmal dyspnea, pulmonary edema</p>\n</td>\n<td>\n<p>Probably a sudden failure of left heart output to keep up with the right heart output &rarr;acute rise in pulmonary venous and capillary pressure &rarr;transudation of fluid into air spaces.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Orthopnea</p>\n</td>\n<td>\n<p>Normal pooling of blood in lungs in supine position added to the already congested pulmonary vascular system; increased venous return not put out by the left ventricle. (Relieved by sitting up, raising the head of the bed, lying on extra pillows.)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiac dilation</p>\n</td>\n<td>\n<p>Greater ventricular end-diastolic volume.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/ce1ad36d87d443b4a5c123778a353219.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5373",
      "difficulty": "medium"
    },
    {
      "text": "A patient on anti-depressants presented to you with hypotension. An ECG was done, which showed wide QRS complexes and right axis deviation. How will you manage this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Antiarrhythmics"
        },
        {
          "id": 2,
          "text": "Intravenous sodium bicarbonate"
        },
        {
          "id": 3,
          "text": "Propranolol"
        },
        {
          "id": 4,
          "text": "Phenytoin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario along the ECG changes described suggests a diagnosis of <strong>tricyclic antidepressant toxicity</strong>. This can be managed with <strong>intravenous sodium bicarbonate</strong>.&nbsp;</p>\n<p>Tricyclic antidepressants (TCAs) are used in the treatment of <strong>psychotic depression</strong>, insomnia, and several pain conditions. Their mechanism of action is inhibition of norepinephrine and serotonin reuptake. They have a <strong>quinidine-like sodium channel blockade effect</strong> on <strong>cardiac</strong> conduction. Hence, they cause<strong> QT prolongation</strong>.&nbsp;Other cardiotoxic effects include atrioventricular (AV) block and<strong> hypotension</strong>. <strong>Rightward-axis deviation</strong> is also an associated finding.</p>\n<p>TCA toxicity can result in <strong>ventricular tachyarrhythmias</strong>, status epilepticus, hyperthermia, and coma. It&nbsp;can also result in <strong>anticholinergic syndrome</strong> due to muscarinic receptor antagonism. Symptoms include dilated pupils, high temperature, dry mouth, and myoclonic movements. It is managed with&nbsp;intravenous sodium bicarbonate bolus (50-100 mEq). This helps in the reversal of sodium channel blockade. <strong>Gastric lavage</strong> and administration of activated charcoal can be carried out in cases of recent ingestion.</p>\n<p>Other side effects of TCAs include urinary retention, tachycardia, and <strong>postural hypotension</strong>. ECG changes such as <strong>T wave inversion</strong> or suppression are also common.&nbsp;</p>\n<p>In some cases, it can result in polymorphic ventricular tachycardias with QT prolongation known as<strong> torsades de pointes</strong>. Recurrent episodes can be treated with <strong>intravenous magnesium sulfate</strong>.&nbsp;</p>\n<p>Other options:</p>\n<p>Option A: Class IA, IC, and III antiarrhythmic drugs are <strong>contraindicated</strong> as they potentiate the action of TCAs.</p>\n<p>Option B: <strong>Propranolol</strong> is a <strong>class II antiarrhythmic</strong> that can cause <strong>wide QRS complexes</strong>. It is used for rate control in atrial fibrillation, angina, and hypertension.&nbsp;</p>\n<p>Option D: <strong>Phenytoin&nbsp;</strong>is an&nbsp;<strong>antiepileptic</strong>&nbsp;used for the treatment of generalized tonic-clonic seizures and focal seizures. It <strong>inactivates sodium channels</strong> and stabilizes neuronal membranes. It can<strong> displace</strong> TCAs from their protein binding sites which can result in transient overdose symptoms.&nbsp;</p><hr><h3>Related Pearl: ECG patterns of various ventricular arrhythmias</h3><p>Ventricular tachycardia</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/097b95729fa14ac68da475ce6288a968x1088x570.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Polymorphic ventricular tachycardia associated with QTc prolongation- Torsades de pointes</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a8ebe0b5757c4efca4f5dd15c6d24e99x1268x324.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Ventricular flutter</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/666962cd0f424000b7e84123f719f120x502x282.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Ventricular fibrillation</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/25067efa869941baa6a40b54599b371ax1049x213.PNG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Etiology of Torsade De Pointes</h3><p><strong>Acquired prolongation of QT interval</strong></p>\n<p><strong>Electrolyte abnormalities</strong></p>\n<ul>\n<li>Hypokalemia</li>\n<li>Hypomagnesemia</li>\n<li>Hypocalcemia</li>\n</ul>\n<p><strong>Drugs</strong></p>\n<ul>\n<li><strong>Antiarrhythmic drugs</strong>\n<ul>\n<li>Class IA: Quinidine, disopyramide, procainamide</li>\n<li>Class III: Sotalol, amiodarone (QT prolongation common but torsade ventricular tachycardia is rare), ibutilide, dofetilide, almokalant</li>\n</ul>\n</li>\n<li><strong>Antibiotics</strong>\n<ul>\n<li>Macrolides: Erythromycin, clarithromycin, azithromycin</li>\n<li>Fluoroquinolones: Levofloxacin, moxifloxacin, gatifloxacin</li>\n<li>Trimethoprim-sulfamethoxazole</li>\n<li>Clindamycin</li>\n<li>Pentamidine</li>\n<li>Chloroquine</li>\n<li>Antifungals: Ketoconazole, itraconazole</li>\n<li>Antivirals</li>\n<li>Antipsychotics</li>\n<li>Antihistamines</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Drugs causing QT prolongation and torsades de pointes</h3><p>Drugs Associated with QT Prolongation and Torsades de Pointes:</p>\n<p>Antiarrhythmics:</p>\n<ul>\n<li>Sotalol</li>\n<li>Amiodarone</li>\n<li>Quinidine</li>\n<li>Procainamide</li>\n<li>Dofetilide</li>\n<li>Ibutilide</li>\n</ul>\n<p>Antimicrobials:</p>\n<ul>\n<li>Levofloxacin</li>\n<li>Ciprofloxacin</li>\n<li>Gatifloxacin</li>\n<li>Moxifloxacin</li>\n<li>Clarithromycin</li>\n<li>Erythromycin</li>\n<li>Ketoconazole</li>\n<li>Itraconazole</li>\n<li>Rilpivirine</li>\n</ul>\n<p>Antidepressants:</p>\n<ul>\n<li>Amitriptyline</li>\n<li>Desipramine</li>\n<li>Imipramine</li>\n<li>Doxepin</li>\n<li>Fluoxetine</li>\n<li>Sertraline</li>\n<li>Venlafaxine</li>\n</ul>\n<p>Antipsychotics:</p>\n<ul>\n<li>Haloperidol</li>\n<li>Droperidol</li>\n<li>Quetiapine</li>\n<li>Ziprasidone</li>\n<li>Thioridazine</li>\n</ul>\n<p>Others:</p>\n<ul>\n<li>Cisapride</li>\n<li>Sumatriptan</li>\n<li>Zolmitriptan</li>\n<li>Arsenic</li>\n<li>Dolasetron</li>\n<li>Methadone<br />&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5414",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents to you with fever, night sweats, ptosis, and bilateral facial nerve palsy. Investigations showed leukocytosis and bilateral hilar lymphadenopathy. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Sarcoidosis"
        },
        {
          "id": 2,
          "text": "Tuberculosis"
        },
        {
          "id": 3,
          "text": "Lymphoma"
        },
        {
          "id": 4,
          "text": "Hypersensitive pneumonitis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical vignette points to a diagnosis of <strong>sarcoidosis</strong>.</p>\n<p>Sarcoidosis is a <strong>granulomatous inflammatory</strong> condition with multisystem involvement. The most common organs affected are the<strong> lungs</strong>, liver, eye, and skin. The most widely accepted etiological hypothesis is an inflammatory response to an infectious or non-infectious trigger in a susceptible host.</p>\n<p>There are two syndromes that are associated with the condition.</p>\n<ul>\n<li><strong>Lofgren's syndrome</strong> is characterized by <strong>erythema nodosum</strong> and<strong> hilar adenopathy</strong>. Periarticular arthritis can also be seen.</li>\n<li><strong>Mikulicz syndrome</strong> is bilateral involvement of <strong>parotid</strong>, submaxillary, and sublingual glands.&nbsp;</li>\n</ul>\n<p>The most common presenting features are <strong>cough</strong>, dyspnea, <strong>fever</strong>, <strong>night sweats</strong>, and weight loss.&nbsp; The eyes can be involved in the form of anterior uveitis, photophobia, dry eyes, and <strong>blurred vision</strong>. Neurological involvement in the form of myelopathy, basilar meningitis, and <strong>facial nerve paralysis</strong>.&nbsp;Skin involvement can be seen as <strong>maculopapular lesions</strong>, keloid formation, ad subcutaneous nodules. <strong>Lupus pernio</strong> refers to the skin involvement of the bridge of the nose, periocular region, and cheeks and points to a chronic state.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9a86ad5099314c699af23e122f10db8bx1200x787.JPEG\" alt=\"Explanation Image\"><p>Histopathological examination reveals <strong>non-necrotizing granulomas</strong> made of macrophages and giant cells. Calcium and protein concretions known as <strong>Schaumann bodies</strong> and stellate inclusions called <strong>asteroid bodies</strong> may be seen within the giant cells.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a196b072f844e0492558c527db32cf9x1279x860.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9b417338f3d342bc9a1c48a8d9d2acb2x1280x1170.JPEG\" alt=\"Explanation Image\"><p>Chest X-ray is preferred to stage lung involvement as follows.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c64befe8ea194301a12bdb6c6797223dx1280x5233.JPEG\" alt=\"Explanation Image\"><p>CT features include <strong>peribronchial thickening</strong> and reticular nodular changes. Glucocorticoids are the drug of choice for management.</p>\n<p>Other options:</p>\n<p>Option B - <strong>Tuberculosis</strong> (TB) is a chronic granulomatous systemic disease. The underlying pathophysiology is <strong>type IV hypersensitivity</strong> reaction. It can present as pulmonary or extrapulmonary TB. Symptoms include <strong>fever</strong>, <strong>night sweats</strong>, weight loss, cough, and hemoptysis. Histopathological examination reveals <strong>caseating tubercles</strong> with multinucleated giant cells and epitheloid cells.</p>\n<p>Option C - Lymphomas are broadly classified into <strong>Non-Hodgkin's lymphoma</strong> (NHL) and <strong>Hodgkin's lymphoma</strong>. Symptoms include fever, weight loss, night sweats, lymphadenopathy, and <strong>splenomegaly</strong>.</p>\n<p>Option D - <strong>Hypersensitivity pneumonitis</strong> arises due to inhalation of antigenic triggers which result in an inflammatory response. Symptoms include <strong>fever</strong>, chills, malaise, and dyspnea. <strong>Cough</strong>, weight loss, and fatigue can be seen in chronic cases.&nbsp;</p><hr><h3>Related Pearl: Eggshell calcification of lymph node on chest X-ray</h3><p>Eggshell calcification refers to fine calcification seen at the periphery of a lymph node. Causes are -</p>\n<ul>\n<li><strong>Silicosis</strong> (most common)</li>\n<li>Sarcoidosis</li>\n<li>Post radiotherapy</li>\n<li>Post-irradiation lymphoma</li>\n<li>Histoplasmosis</li>\n<li>Blastomycosis</li>\n<li>Amyloidosis</li>\n<li>Tuberculosis</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4a4d813b4cc64ebbb0bdff38920873e8x1280x930.PNG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Causes of miliary shadow in Chest X-ray</h3><p>Miliary shadow&nbsp;refers to innumerable, small&nbsp;(1-4 mm) pulmonary nodules&nbsp;scattered throughout the&nbsp;lungs. It is seen in -&nbsp;</p>\n<ul>\n<li><strong>Miliary tuberculosis</strong></li>\n<li>Histoplasmosis</li>\n<li><strong>Sarcoidosis</strong></li>\n<li>Pneumoconiosis &ndash; coal workers pneumoconiosis and silicosis</li>\n<li>Healed varicella</li>\n<li><strong>Long-standing MS</strong> &ndash; can lead to pulmonary hemosiderosis</li>\n<li>Alveolar microlithiasis</li>\n<li>Papillary and medullary Ca thyroid</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cd37e41e724146cd94276c610fdefbbcx720x568.PNG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Types of granulomas</h3><table>\n<tbody>\n<tr>\n<td><strong>GRANULOMA</strong></td>\n<td><strong>SEEN IN</strong></td>\n</tr>\n<tr>\n<td>Noncaseating granuloma</td>\n<td>\n<p>Crohn&rsquo;s disease</p>\n<p>Leprosy</p>\n<p>Sarcoidosis</p>\n<p>Hodgkin&rsquo;s lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>Caseating granuloma</td>\n<td>\n<p>Tuberculosis</p>\n<p>Histoplasmosis</p>\n<p>Syphilis</p>\n<p>Coccidiomycosis</p>\n</td>\n</tr>\n<tr>\n<td>Foreign body granuloma</td>\n<td>\n<p>Silicosis</p>\n<p>Berylliosis</p>\n</td>\n</tr>\n<tr>\n<td>Immune granuloma</td>\n<td>\n<p>Wegener&rsquo;s granulomatosis</p>\n<p>Giant cell arteritis</p>\n</td>\n</tr>\n<tr>\n<td>Durck&rsquo;s granuloma</td>\n<td>Cerebral malaria</td>\n</tr>\n<tr>\n<td>Stellate granuloma</td>\n<td>Cat scratch disease</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5352",
      "difficulty": "easy"
    },
    {
      "text": "A 35-year-old female patient presents to you with fever, breathlessness, and cough with expectoration. A CT scan was done which is shown below. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Consolidation with air bronchogram"
        },
        {
          "id": 2,
          "text": "Mediastinal mass"
        },
        {
          "id": 3,
          "text": "Pleural effusion"
        },
        {
          "id": 4,
          "text": "Diaphragmatic hernia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given history and the CT scan image are highly suggestive of <strong>pneumonia</strong> in which,&nbsp;<strong>consolidation with an air bronchogram</strong> can be seen.</p>\n<p>A patient presenting with <strong>fever,</strong> <strong>breathlessness</strong>, and <strong>cough</strong> with <strong>expectoration</strong> is most likely suffering from pneumonia. Other symptoms include nausea, vomiting, diarrhea, fatigue, headache, myalgias, arthralgias, etc. The CT image shows a <strong>sharply demarcated homogenous</strong> <strong>consolidation</strong> that crosses segmental boundaries and involves only a <strong>single lobe</strong>. It is suggestive of <strong>lobar</strong> <strong>pneumonia</strong>.&nbsp;</p>\n<p>In lobar pneumonia, the infection develops within the distal airspaces. It spreads via the collateral air drift and produces <strong>homogenous opacification</strong> of complete or partial lung segments. The airways remain patent as they are not primarily involved. <strong>Patent bronchi</strong> may be seen within the area of consolidation called <strong>air bronchograms</strong>. Total resolution of the opacification occurs within 4-6 weeks.</p>\n<p>The most common organism implicated in community-acquired adult bacterial pneumonia is <em><strong>S</strong><strong>treptococcus</strong><strong> pneumoniae</strong></em>. Some of the predisposing factors include:</p>\n<ul>\n<li>Chronic illness</li>\n<li>Splenectomy</li>\n<li>Alcoholism</li>\n<li>Sickle cell disease</li>\n</ul>\n<p>Other options:</p>\n<p>Option B: A <strong>mediastinal mass</strong> can be in one of the three mediastinal compartments namely the&nbsp;<strong>anterior</strong>, <strong>middle,</strong>&nbsp;or&nbsp;<strong>posterior</strong> compartment. CT scan is the only imaging modality that should be done for the evaluation in most instances. <strong>Barium studies</strong> are indicated in patients with<strong> posterior</strong> mediastinal masses. Given below is a CT image of a large mass in the left <strong>anterior</strong> mediastinum, most likely a <strong>thymoma</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/08d62b64991b45bfa0ef589da70c390bx1280x958.PNG\" alt=\"Explanation Image\"><p>Option C:<strong> Pleural effusion</strong> is the accumulation of fluid within the pleural space. It can be either <strong>transudative</strong> (seen in cardiac failure) or <strong>exudative</strong> (seen in malignancies, infections, pulmonary embolism, etc.). On a CT image, pleural effusion appears as a dependent <strong>sickle-shaped opacity</strong> of low attenuation. The image below shows a CT image of right-sided pleural effusion.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/07cf1c18b7234474b45b34cda9e6dd51x1280x920.PNG\" alt=\"Explanation Image\"><p>Option D: <strong>Diaphragmatic hernia</strong> occurs due to intrathoracic movement of the abdominal contents through a <strong>diaphragmatic</strong> <strong>defect</strong>. The types include:</p>\n<ul>\n<li><strong>Bochdalek hernia</strong> (posterior): <strong>Most common</strong> <strong>type</strong>. Herniation occurs through the pleuroperitoneal foramen.</li>\n<li><strong>Morgagni</strong> <strong>hernia</strong> (anterior): Herniation occurs through the foramen of Morgagni.</li>\n</ul>\n<p>Given below is a CT image showing Bochdalek hernia.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4166145e8674425d8bed0002771c61bbx1280x873.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Empirical Antibiotic Treatment of Community-Acquired Pneumonia (CAP)</h3><table>\n<tbody>\n<tr>\n<td>Situation&nbsp;</td>\n<td>Treatment Regimen</td>\n</tr>\n<tr>\n<td>&nbsp;<strong>Outpatient</strong></td>\n<td>\n<p><strong>Previously healthy</strong>:</p>\n<p>&nbsp;Macrolide / Doxycycline</p>\n<p><strong>Comorbidities</strong>:</p>\n<p>Respiratory Fluoroquinolone&nbsp;</p>\n<p><strong>&nbsp; &nbsp; &nbsp; Or&nbsp;&nbsp;</strong>&nbsp; &nbsp; &nbsp;</p>\n<p>&beta;-lactam + Macrolide / Doxycycline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inpatients</strong></p>\n<p><strong>Non - ICU</strong></p>\n</td>\n<td>\n<p>Respiratory<strong>&nbsp;</strong>Fluoroquinolone&nbsp;</p>\n<p><strong>Or&nbsp;</strong></p>\n<p>&beta;-lactam&nbsp;<strong>+</strong>&nbsp;Macrolide / Doxycycline</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Inpatients</strong></p>\n<p><strong>ICU</strong></p>\n</td>\n<td>\n<p>&beta;-lactam</p>\n<p><strong>+</strong></p>\n<p>Respiratory Fluoroquinolone <strong>Or</strong>&nbsp;Azithromycin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\"><strong>If Pseudomonas</strong></p>\n&nbsp;</td>\n<td>\n<p><strong>&nbsp;</strong>Anti-pseudomonal&nbsp;&beta;-lactam</p>\n<p><strong>+</strong></p>\n<p>Fluoroquinolone*&nbsp;<strong>Or</strong> Aminoglycoside</p>\n<p><strong>+ </strong></p>\n<p>Azithromycin</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p class=\"p1\"><strong>If CA-MRSA</strong></p>\n</td>\n<td>\n<p>Site based regimen</p>\n<p><strong>+</strong></p>\n<p>Linezolid <strong>Or&nbsp;</strong>Vancomycin</p>\n<p><strong>+</strong></p>\n<p>Clindamycin&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Note:</strong></p>\n<p>Macrolide - Azithromycin / Clarithromycin</p>\n<p>Fluoroquinolones :</p>\n<ul>\n<li>Respiratory Fluoroquinolone - Levofloxacin* / Moxifloxacin / (Gemifloxacin - only outpatient)&nbsp;</li>\n<li>Ciprofloxacin*</li>\n</ul>\n<p>&beta;-lactam :</p>\n<ul>\n<li>Outpatient with comorbidities&nbsp;\n<ul>\n<li>PO - Amoxicillin (+/- clavulanate)/ Cefpodoxime / Cefuroxime&nbsp;</li>\n<li>IV - Ceftriaxone</li>\n</ul>\n</li>\n<li>Inpatient, Non-ICU (IV)&nbsp;\n<ul>\n<li>Ampicillin / Ceftriaxone / Cefotaxime / Ertapenem</li>\n</ul>\n</li>\n<li>Inpatient, ICU (IV)&nbsp;\n<ul>\n<li>Ampicillin-Sulbactam / Ceftriaxone / Cefotaxime</li>\n</ul>\n</li>\n<li>Anti-pseudomonal&nbsp;&beta;-lactam (IV)&nbsp;\n<ul>\n<li>Piperacillin-Tazobactam / Cefepime / Imipenem / Meropenem&nbsp;</li>\n</ul>\n</li>\n</ul>\n<p class=\"p1\">Aminoglycoside - Amikacin / T<span class=\"s1\">obramycin</span></p><hr><h3>Related Pearl: Lobes involved in various lung diseases</h3><p>Mnemonic to easily remember the lobe of lung involved in CTD is:</p>\n<p>Upper Lobe - <strong>CHARTS</strong></p>\n<ul>\n<li><strong>C</strong>oal workers pneumoconiosis (CWP), silicosis, berylliosis</li>\n<li><strong>H</strong>istiocytosis X (LCH)</li>\n<li><strong>A</strong>nkylosing spondylitis, ABPA</li>\n<li><strong>R</strong>adiation</li>\n<li><strong>T</strong>uberculosis</li>\n<li><strong>S</strong>arcoidosis</li>\n</ul>\n<p>Lower lobes - <strong>RAIDS</strong></p>\n<ul>\n<li><strong>R</strong>heumatoid arthritis</li>\n<li><strong>A</strong>sbestosis</li>\n<li><strong>I</strong>diopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP)</li>\n<li><strong>D</strong>rugs: bleomycin, busulfan, amiodarone, methotrexate, nitrofurantoin</li>\n<li><strong>S</strong>cleroderma</li>\n</ul><hr><h3>Related Pearl: Typical Pneumonia  v/s  Atypical Pneumonia</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Typical pneumonia</strong>&nbsp;</span></td>\n<td><span><strong>Atypical pneumonia&nbsp;</strong></span></td>\n</tr>\n<tr>\n<td><span>Extracellular organism&nbsp;</span></td>\n<td><span>Intracellular organism</span></td>\n</tr>\n<tr>\n<td><span>Alveolar exudates in air spaces </span></td>\n<td><span>Interstitial involvement</span><br /><br /></td>\n</tr>\n<tr>\n<td><span>Neutrophilic in nature</span></td>\n<td><span>Lymphocytic in nature</span></td>\n</tr>\n<tr>\n<td><span>High-grade fever</span></td>\n<td><span>Low-grade fever</span></td>\n</tr>\n<tr>\n<td><span>Productive cough</span></td>\n<td>\n<p><span>Dry cough</span><br /><span>hemoptysis &nbsp;&nbsp;</span><span>scanty sputum</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Pleuritic chest pain </span></td>\n<td><span>Extrapulmonary manifestation</span></td>\n</tr>\n<tr>\n<td><span>X-Ray shows large areas of consolidation</span></td>\n<td><span>X-Ray shows an interstitial pattern of involvement.</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li><span>The most common cause of <strong>Community-acquired Pneumonia</strong>- <em>Streptococcus pneumoniae.</em></span></li>\n<li><span>The most common cause of <strong>Atypical Pneumonia</strong>- <em>Mycoplasma&nbsp;pneumoniae.</em></span></li>\n<li><span>The most common&nbsp;cause of <strong>Nosocomial Pneumonia</strong>-</span>\n<ul>\n<li><span>Overall- gram-negative bacilli (implicated as a group)</span></li>\n<li><span>The single most common agent-&nbsp;<em>Staphylococcus aureus</em> (i.e.,&nbsp;gram-positive cocci)</span></li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/788eb4488f054109ae5a0d183c4128c5x1280x732.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/2e0977a560bd4912a11f420856e15cbf.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5427",
      "difficulty": "easy"
    },
    {
      "text": "A 25-year-old patient is undergoing tooth extraction for dental caries. Which of the following does not require prophylaxis against infective endocarditis?",
      "choices": [
        {
          "id": 1,
          "text": "Prior history of endocarditis"
        },
        {
          "id": 2,
          "text": "Atrial septal defect"
        },
        {
          "id": 3,
          "text": "Unrepaired cyanotic heart disease"
        },
        {
          "id": 4,
          "text": "Prosthetic heart valves"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Atrial septal defect</strong> is <strong>not</strong> considered a high-risk condition that warrants prophylaxis against <strong>infective endocarditis</strong>.</p>\n<p>Bacterial or fungal infection of the valvular or endocardial surface of the heart is known as infective endocarditis.<strong> Large friable vegetations</strong> on the heart valves composed of fibrin, inflammatory cells, and organisms are characteristic of the condition. Predisposing conditions include mitral valve prolapse, ventricular septal defect, rheumatic heart disease, intravenous drug use, and <strong>prosthetic valves</strong>.</p>\n<p><strong>Prophylaxis</strong> against infective endocarditis is recommended during certain <strong>dental procedures</strong> and <strong>respiratory tract procedures</strong>. In patients not allergic to penicillin, <strong>2g of amoxicillin</strong> can be given <strong>orally</strong> one hour before the procedure. Another option is to administer <strong>2g of ampicillin intravenously</strong> or intramuscularly 30 minutes before the procedure.&nbsp;Though prophylaxis is not advised, it is recommended that skin and genitourinary tract infections be treated before undergoing the procedure at these sites.</p>\n<p>The most common organisms responsible are <em><strong>Staphylococcus aureus</strong></em>, streptococci, and pneumococci. The <strong>oral cavity</strong> is the portal for <strong>viridans streptococci</strong>.&nbsp;<strong> Staphylococci</strong> are responsible for <strong>early</strong> prosthetic valve endocarditis. In <strong>late</strong> prosthetic valve endocarditis, <strong>streptococci</strong> are commonly implicated.&nbsp;</p>\n<p>Clinical features include subungual splinter hemorrhages, <strong>Osler nodes</strong>, Janeway lesions, and <strong>Roth spots</strong>.&nbsp;</p>\n<p>The image below shows Osler nodes which are painful raised violaceous lesions commonly affecting the <strong>fingers</strong>, toes, and feet. It is immunologically mediated.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/989c12894db244f09ea42d9b879dc235x720x540.JPEG\" alt=\"Explanation Image\"><p>The image below depicts Roth's spots which are <strong>exudative lesions</strong> in the retina. This is an immunological phenomenon.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/986be3c99e87400d85cc92cc57abad92x720x548.JPEG\" alt=\"Explanation Image\"><p>The image given below shows Janeway lesions which are vascular lesions and not immunologically mediated.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fbc88684483245a28dbb78ff9c514b13x600x468.JPEG\" alt=\"Explanation Image\"><p>Symptoms such as dyspnea, cough, arthralgias, and flank pain can also arise due to <strong>embolization</strong> or immunologically mediated phenomena.&nbsp;</p>\n<p>Antibiotics are the mainstay in management. In certain cases, surgical management is necessary.</p>\n<p>Other options:&nbsp;</p>\n<p>Options A, B, and C - According to American Heart Association (AHA),&nbsp;<strong>prior history of endocarditis</strong>, <strong>unrepaired cyanotic heart disease</strong>, and <strong>prosthetic heart valves</strong> are all high-risk cardiac lesions that necessitate antibiotic prophylaxis.</p><hr><h3>Related Pearl: Vegetations in Various Types of Endocarditis</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>RHD</strong></p>\n</td>\n<td>\n<p><strong>Infective endocarditis</strong></p>\n</td>\n<td>\n<p><strong>Non- bacterial thrombotic or marantic endocarditis</strong></p>\n</td>\n<td>\n<p><strong>Libman&ndash;Sacks endocarditis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Etiology</strong></p>\n</td>\n<td>\n<p>Rheumatic</p>\n<p>heart disease</p>\n</td>\n<td>\n<p>Infective endocarditis</p>\n</td>\n<td>\n<p>Malignancy</p>\n<p>(M3-AML, pancreatic</p>\n<p>carcinoma), deep</p>\n<p>vein thrombosis,</p>\n<p>Trosseau syndrome</p>\n</td>\n<td>\n<p>Systemic lupus erythematosus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Vegetations</strong></p>\n</td>\n<td>\n<p>Small, warty</p>\n<p>Firm</p>\n<p>Friable</p>\n</td>\n<td>\n<p>Large</p>\n<p>Bulky</p>\n<p>friable,</p>\n<p>destructive</p>\n</td>\n<td>\n<p>Small, single or multiple, non- destructive</p>\n</td>\n<td>\n<p>Small to medium-sized, flat, verrucuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Site</strong></p>\n</td>\n<td>\n<p>Along lines of closure</p>\n</td>\n<td>\n<p>Cusps of valves, mural endocardium</p>\n</td>\n<td>\n<p>Line of closure</p>\n</td>\n<td>\n<p>Either or</p>\n<p>both sides of the valve leaflets.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sterile/Infective</strong></p>\n</td>\n<td>\n<p>Sterile</p>\n</td>\n<td>\n<p>Non-sterile</p>\n</td>\n<td>\n<p>Sterile</p>\n</td>\n<td>\n<p>Sterile</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Embolisation</strong></p>\n</td>\n<td>\n<p>Uncommon</p>\n</td>\n<td>\n<p>Very common</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Uncommon</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8cbba8132d2c40e08cdaa19e5a970968x1280x2262.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Modified Duke's criteria for diagnosis of infective endocarditis</h3><div class=\"page\" title=\"Page 2415\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Diagnosis of Infective endocarditis is by Duke's Criteria, which requires either:</p>\n</div>\n</div>\n</div>\n</div>\n<ol>\n<li>Pathologic criteria</li>\n<li>Clinical criteria</li>\n</ol>\n<p>If clinical criteria are used, definitive endocarditis is defined by the presence of&nbsp;<strong>2 major </strong>or&nbsp;<strong>1 major + 3 minor </strong>or&nbsp;<strong>5 minor criteria.</strong></p>\n<p>The presence of single pathological criteria is definitive of infective endocarditis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/186ed21749ed4d3ab7e43344abb39a78x1200x2770.JPEG\" alt=\"Pearl Image\"><p>Note:&nbsp;The diagnosis of endocarditis is rejected if an alternative diagnosis is established either when:</p>\n<ul class=\"p-rich_text_list p-rich_text_list__bullet\" data-stringify-type=\"unordered-list\" data-indent=\"0\" data-border=\"0\">\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Symptoms resolve and do not recur with &lt;4 days of antibiotic therapy OR</li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">If surgery or autopsy yields no pathologic or macroscopic evidence of endocarditis in &lt;4 days of antimicrobial therapy.</li>\n</ul><hr><h3>Related Pearl: Cardiac conditions requiring antibiotic prophylaxis for infective endocarditis</h3><p>High risk cardiac conditions for development of Infective endocarditis and require antibiotic prophylaxis are:</p>\n<ul>\n<li>Prosthetic valves</li>\n<li>History of infective endocarditis</li>\n<li>Few congenital heart diseases which include:<br />\n<ul>\n<li>Unrepaired cyanotic CHD, including palliative shunts and conduit</li>\n<li>Completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure</li>\n<li>Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device</li>\n</ul>\n</li>\n<li>Cardiac transplantation recipients with cardiac valvular disease</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5377",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents to the emergency department with a history of ingestion of ten tablets of paracetamol.  He has developed oliguria and liver function tests show deranged values. Which of the following can be used in the management of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "N-acetylcysteine"
        },
        {
          "id": 2,
          "text": "Dopamine"
        },
        {
          "id": 3,
          "text": "Ursodeoxycholic acid"
        },
        {
          "id": 4,
          "text": "Furosemide"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical vignette suggests <strong>acetaminophen</strong> (Paracetamol)&nbsp;<strong>toxicity,</strong>&nbsp;which can be managed with <strong>N-acetylcysteine</strong>.&nbsp;</p>\n<p>Early manifestations (within 4-12 hours) of&nbsp;<strong>acetaminophen</strong>&nbsp;<strong>toxicity</strong> include nausea, vomiting, diarrhea, and abdominal pain. Later, <strong>renal failure</strong> and myocardial injury may be seen. <strong>Low bilirubin</strong> levels along with <strong>raised aminotransferase</strong> levels are characteristic of the condition.&nbsp;</p>\n<p>Acetaminophen toxicity is an important cause of <strong>acute liver failure</strong>. Ingestion of&nbsp;&ge;25g can be fatal. Cytochrome P450 CYP2E1 metabolizes acetaminophen to <strong>N-acetyl-p-benzoquinone-imine</strong> (NAPQI). <strong>Glutathione</strong> is responsible for its detoxification, after which it is excreted in the urine. When glutathione reserves are depleted or large amounts of NAPQI are formed, it binds to hepatocyte macromolecules. This can then lead to <strong>hepatocyte necrosis</strong>.</p>\n<p>Initial management includes <strong>gastric lavage</strong> and oral charcoal or <strong>cholestyramine</strong>. It should be carried out within thirty minutes of ingestion. If they are used, gastric lavage must be done afterward before using another agent. Acetaminophen blood levels can be estimated from a nomogram plot. In patients with high acetaminophen levels, <strong>intravenous</strong> N-acetylcysteine administration within 8 hours of ingestion is recommended. It helps in the replenishment of glutathione. It is partially effective even up to 36 hours. <strong>Liver transplantation</strong> is necessary if signs of hepatic failure continue despite therapy.&nbsp;</p>\n<p>Other options:&nbsp;</p>\n<p>Option B: <strong>Dopamine</strong> is a neurotransmitter that is used in severe congestive cardiac failure. It acts on &beta;-1 receptors at a dose of 2-10 mcg/kg/minute.&nbsp;</p>\n<p>Option C:&nbsp;<strong>Ursodeoxycholic acid</strong> is a bile acid that is the first-line treatment for <strong>primary biliary cholangitis</strong>. It is useful in cholestatic drug hepatotoxicity, but is not recommended.&nbsp;</p>\n<p>Option D:&nbsp;<strong>Furosemide</strong>&nbsp;is a <strong>loop diuretic</strong> commonly used in pulmonary edema and congestive heart failure. Side effects include hyponatremia, hypotension, and ototoxicity.&nbsp;</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Poisoning - Modalities of General Management</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;Management</td>\n<td>Examples</td>\n</tr>\n<tr>\n<td>Gastrointestinal decontamination</td>\n<td>\n<p>Orogastric Lavage</p>\n<p>Activated Charcoal</p>\n<p>Whole Bowel Irrigation</p>\n</td>\n</tr>\n<tr>\n<td>Enhanced elimination</td>\n<td>\n<p>Multidose activated charcoal</p>\n<p>Urinary alkalinization</p>\n<p>Extracorporeal removal(Hemodialysis, Hemoperfusion)</p>\n</td>\n</tr>\n<tr>\n<td>Administration of antidote</td>\n<td>\n<p>Mechanical Antidotes</p>\n<p>Chemical Antidotes</p>\n<p>Physiological Antidotes</p>\n<p>Pharmacological Antidotes</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Certain specific clinical features diagnostic of poisons and poisoning</h3><table>\n<tbody>\n<tr>\n<td><strong>Clinical features</strong></td>\n<td><strong>Possible causes</strong></td>\n</tr>\n<tr>\n<td>Pupillary constriction (Miosis)</td>\n<td>Barbiturates, caffeine, carbamates, carbolic acid (phenol), clonidine, methyl dopa, nicotine, opiates, organophosphates, parasympathomimetics.</td>\n</tr>\n<tr>\n<td>Pupillary dilatation (Mydriasis)</td>\n<td>Alcohol (constricted in coma), amphetamines, antihistamines, benzodiazepines, carbon monoxide, cocaine, cyanide, datura (atropine), ephedrine</td>\n</tr>\n<tr>\n<td><strong>Hippus (alternate constriction and dilatation of pupils)</strong></td>\n<td><strong>Aconite, alcohol, barbiturates.</strong></td>\n</tr>\n<tr>\n<td>Nystagmus</td>\n<td>Alcohol, barbiturates, carbamazepine, phencyclidine, phenytoin</td>\n</tr>\n<tr>\n<td>Pinpoint pupils, and reduced respiratory rate</td>\n<td>Opioids, cholinesterase inhibitors (organophosphorus or carbamate insecticides), clonidine, phenothiazines, Pontine hemorrhage</td>\n</tr>\n<tr>\n<td>Cyanosis</td>\n<td>Any CNS depressant or agent causing methemoglobinemia</td>\n</tr>\n<tr>\n<td>Needle tracks, pinpoint pupils, and reduced respiratory rate</td>\n<td>IV Opioids</td>\n</tr>\n<tr>\n<td>Dilated pupils or mid-point pupils, and reduced respiratory rate</td>\n<td>Benzodiazepines</td>\n</tr>\n<tr>\n<td>Dilated pupils, tachycardia</td>\n<td>\n<ul>\n<li>Tricyclic antidepressants &ndash; dry mouth, warm peripheries, may also be twitchy or have seizures</li>\n<li>Amphetamines, ecstasy, cocaine &ndash; may also be hallucinating or agitated</li>\n<li>Anticholinergic drugs such as benzhexol, benztropine &ndash; may also have hyperreflexia and myoclonus</li>\n<li>Antihistamines &ndash; may also be drowsy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Increased salivation</td>\n<td>Organophosphorus or carbamate insecticides</td>\n</tr>\n<tr>\n<td>\n<p>Hypothermia</p>\n<p>&nbsp;</p>\n</td>\n<td>Lithium, tricyclic antidepressants, anticholinergics, antihistamines</td>\n</tr>\n<tr>\n<td>\n<p>Hyperthermia</p>\n</td>\n<td>\n<ul>\n<li>Amphetamines, ecstasy, cocaine (also hypertension, tachycardia, agitation, rhabdomyolysis)</li>\n<li>Neuroleptic malignant syndrome (also confusion, fluctuating consciousness, rigidity, tremor, autonomic instability, sweating, rhabdomyolysis)</li>\n<li>Serotonin syndrome (also agitation, clonus, tremor, hyperreflexia, sweating, tachycardia)</li>\n<li>Salicylates including aspirin (also tachycardia, metabolic acidosis, restlessness, hyperventilation)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hypertension</td>\n<td>Amphetamine, ephedrine, cocaine, clonidine, MAO inhibitors, thyroid hormones</td>\n</tr>\n<tr>\n<td>Hypotension</td>\n<td>Cyanide, alcohol, digitalis, carbon monoxide, narcotics, barbiturates</td>\n</tr>\n<tr>\n<td>Abdominal cramps, diarrhea, tachycardia, restlessness, hallucinations</td>\n<td>Withdrawal from: Alcohol, benzodiazepines, opioids</td>\n</tr>\n<tr>\n<td>Bradycardia</td>\n<td>Beta-blockers, calcium antagonists (not dihydropyridines), digoxin, opioids, organophosphorus insecticides, centrally acting alpha agonists, e.g. clonidine</td>\n</tr>\n<tr>\n<td>Seizures</td>\n<td>Tricyclic antidepressants, theophylline, antihistamines, anticonvulsants, non-steroidal drugs, phenol, phenothiazines, isoniazid, cocaine, carbon monoxide, organophosphorus insecticides, strychnine</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Specific antidotes for poisoning</h3><table>\n<tbody>\n<tr>\n<td><strong>ANTIDOTE</strong></td>\n<td><strong>POISONING</strong></td>\n</tr>\n<tr>\n<td><strong>4-methyl pyrazole</strong></td>\n<td>Methanol and ethylene glycol</td>\n</tr>\n<tr>\n<td><strong>100% oxygen </strong></td>\n<td>Carbon monoxide, cyanide, methemoglobinemia</td>\n</tr>\n<tr>\n<td><strong>Ammonium chloride </strong></td>\n<td>Phencyclidine, amphetamine</td>\n</tr>\n<tr>\n<td><strong>Amyl nitrate </strong></td>\n<td>Cyanide, hydrogen sulphide</td>\n</tr>\n<tr>\n<td><strong>Atropine</strong></td>\n<td>Carbamate and organophosphorus poisoning</td>\n</tr>\n<tr>\n<td><strong>Bupropion</strong></td>\n<td>Nicotine</td>\n</tr>\n<tr>\n<td><strong>Calcium disodium edetate</strong></td>\n<td>Cadmium, chromium, cobalt, copper, lead, magnesium, nickel, uranium, zinc</td>\n</tr>\n<tr>\n<td><strong>Calcium gluconate </strong></td>\n<td>Precipitates fluorides, magnesium and oxalates</td>\n</tr>\n<tr>\n<td><strong>Chlorpromazine</strong></td>\n<td>Amphetamine</td>\n</tr>\n<tr>\n<td><strong>Deferoxamine</strong></td>\n<td>Iron, aluminium</td>\n</tr>\n<tr>\n<td><strong>Diazepam</strong></td>\n<td>Amphetamine, chloroquine, alcohol withdrawal</td>\n</tr>\n<tr>\n<td><strong>Dicobalt edetate</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Dimercaprol (BAL)</strong></td>\n<td>Antimony, arsenic, copper, lead, mercury, nickel and gold</td>\n</tr>\n<tr>\n<td><strong>Diphenhydramine</strong></td>\n<td>Phenothiazines and related drugs</td>\n</tr>\n<tr>\n<td><strong>Disodium calcium edetate</strong></td>\n<td><strong>&nbsp;</strong>Lead</td>\n</tr>\n<tr>\n<td><strong>DMPS *, (Unithiol)</strong></td>\n<td><strong>&nbsp;</strong>Mercury</td>\n</tr>\n<tr>\n<td><strong>DMSA ** </strong></td>\n<td><strong>&nbsp;</strong>Lead</td>\n</tr>\n<tr>\n<td><strong>D-Penicillamine (Cuprimine) </strong></td>\n<td>Copper, lead, mercury, chromate, nickel, zinc, arsenic</td>\n</tr>\n<tr>\n<td><strong>Ethanol</strong></td>\n<td>Methanol and ethylene glycol</td>\n</tr>\n<tr>\n<td><strong>Fab fragment</strong></td>\n<td>Digoxin, digitoxin, oleander tea</td>\n</tr>\n<tr>\n<td><strong>Flumazenil</strong></td>\n<td>Benzodiazepine</td>\n</tr>\n<tr>\n<td><strong>Glucagon</strong></td>\n<td>Propranolol and other beta-blockers toxicity</td>\n</tr>\n<tr>\n<td><strong>Hydroxocobalamin</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Labetalol hydrochloride</strong></td>\n<td>Hypertensive crisis due to cocaine</td>\n</tr>\n<tr>\n<td><strong>Methionine</strong></td>\n<td>Paracetamol</td>\n</tr>\n<tr>\n<td><strong>Methylene blue</strong></td>\n<td>Methemoglobinemia</td>\n</tr>\n<tr>\n<td><strong>N-acetylcysteine </strong></td>\n<td>Paracetamol, acetaminophen toxicity</td>\n</tr>\n<tr>\n<td><strong>Nalorphine</strong></td>\n<td>Morphine</td>\n</tr>\n<tr>\n<td><strong>Naloxone (Naltrexone)</strong></td>\n<td>Narcotic, opiates, CNS depressants</td>\n</tr>\n<tr>\n<td><strong>Nicotinamide</strong></td>\n<td>Vacor poisoning, phenylurea pesticide toxicity</td>\n</tr>\n<tr>\n<td><strong>Pancuronium bromide</strong></td>\n<td>Neuromuscular blocking agents</td>\n</tr>\n<tr>\n<td><strong>Penicillamine</strong></td>\n<td>Copper</td>\n</tr>\n<tr>\n<td><strong>Physostigmine salicylate </strong></td>\n<td>Coma, convulsions from anticholinergics</td>\n</tr>\n<tr>\n<td><strong>Pralidoxime (2-PAM) </strong></td>\n<td>Organophosphorus insecticides, nerve agents</td>\n</tr>\n<tr>\n<td><strong>Propranolol</strong></td>\n<td>Cocaine intoxication, beta adrenergics</td>\n</tr>\n<tr>\n<td><strong>Protamine sulphate </strong></td>\n<td>Heparin overdose</td>\n</tr>\n<tr>\n<td><strong>Prussian blue</strong></td>\n<td>Thallium</td>\n</tr>\n<tr>\n<td><strong>Pyridoxine (Vit. B6) </strong></td>\n<td>Isoniazid, hydrazine toxicity</td>\n</tr>\n<tr>\n<td><strong>Sodium bicarbonate </strong></td>\n<td>Urinary alkalinisation for salicylates, phenobarbital</td>\n</tr>\n<tr>\n<td><strong>Sodium nitrite</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Sodium thiosulphate</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Vitamin K</strong></td>\n<td>Warfarin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5393",
      "difficulty": "easy"
    },
    {
      "text": "A female patient with a negative urine pregnancy test presents to you with galactorrhea. An MRI was done which revealed a large pituitary tumor. If the patient is not willing for surgery, which of the following is the best drug for treatment?",
      "choices": [
        {
          "id": 1,
          "text": "Bromocriptine"
        },
        {
          "id": 2,
          "text": "Promethazine"
        },
        {
          "id": 3,
          "text": "Octreotide"
        },
        {
          "id": 4,
          "text": "Clozapine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical vignette points to a diagnosis of <strong>prolactinoma</strong> and the best drug for the treatment of the condition is <strong>bromocriptine</strong>.</p>\n<p>Prolactinomas are pituitary tumors that can present as microadenomas or macroadenomas. Tumors <strong>&lt;1cm</strong> in diameter and no regional invasion are known as <strong>microadenomas</strong>. It is more commonly seen in women. Tumors <strong>&gt;1cm</strong> in size are known as <strong>macroadenomas</strong>. It can be locally invasive. Prolactin levels <strong>&gt;200</strong><span class=\"col\"><strong>&mu;g/L</strong> are suggestive of prolactinomas.&nbsp;</span></p>\n<p><span class=\"col\">Women present with features such as <strong>amenorrhea</strong>, infertility, and <strong>galactorrhea</strong>. <strong>Visual field defects</strong> can also be seen. Symptoms in males include <strong>impotence</strong>, infertility, and loss of libido. An MRI is recommended in all patients who present with hyperprolactinemia.</span></p>\n<p><span class=\"col\">Microadenomas can be managed with regular monitoring of prolactin levels and MRI scans, if fertility is not a requisite. Oral <strong>dopamine agonists</strong> such as <strong>bromocriptine</strong> and cabergoline are used for medical management. They are agonists at <strong>D2 receptors</strong>. Side effects include constipation, nasal stuffiness, and dry mouth. Resistance or intolerance to these drugs requires surgical debulking. Cases that do not respond to medical or surgical management can be treated with radiotherapy.</span></p>\n<p><span class=\"col\">Other options:</span></p>\n<p><span class=\"col\">Option B: <strong>Promethazine</strong> is an antihistamine used to treat<strong> motion sickness</strong>, pruritus, and <strong>oculogyric crisis</strong>.</span></p>\n<p><span class=\"col\">Option C: <strong>Octreotide</strong> is a somatostatin analog that is used in <strong>acromegaly</strong>, variceal bleeding, and hepatorenal syndrome.</span></p>\n<p><span class=\"col\">Option D:<strong> Clozapine</strong> is an atypical antipsychotic used in <strong>refractory schizophrenia</strong> and mania.</span></p><hr><h3>Related Pearl: Factors affecting prolactin secretion</h3><table>\n<tbody>\n<tr>\n<td><strong>Increased Prolactin Secretion</strong></td>\n<td><strong>Decreased Prolactin Secretion</strong></td>\n</tr>\n<tr>\n<td>Sleep</td>\n<td>Dopamine</td>\n</tr>\n<tr>\n<td>Stress</td>\n<td>L-Dopa</td>\n</tr>\n<tr>\n<td>Strenuous exercise</td>\n<td>Apomorphine</td>\n</tr>\n<tr>\n<td>Sexual intercourse in women</td>\n<td>Bromocriptine and related ergot derivatives</td>\n</tr>\n<tr>\n<td>Pregnancy</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Nursing</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Breast stimulation in non-lactating women</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Estrogen</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Hypothyroidism</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>TRH</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Opioids</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Phenothiazines, butyrophenones</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Atypical antipsychotics - Risperidone</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Dopamine synthesis inhibitors - &alpha;-Methyldopa</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p>H<sub>2</sub> antagonists - Cimetidine, ranitidine</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Imipramines - Amitriptyline, amoxapine</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Serotonin reuptake inhibitors -Fluoxetine</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Calcium channel blockers - Verapamil</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p>Thioxanthenes</p>\n<p>Metoclopramide</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Catecholamine depletors - Reserpine</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5398",
      "difficulty": "easy"
    },
    {
      "text": "A patient presents to you with an irregularly irregular pulse of 120/minute and a pulse deficit of 20. Which of the following would be the jugular venous pressure (JVP) finding?",
      "choices": [
        {
          "id": 1,
          "text": "Absent p wave"
        },
        {
          "id": 2,
          "text": "Absent a wave"
        },
        {
          "id": 3,
          "text": "Cannon a wave"
        },
        {
          "id": 4,
          "text": "Raised JVP with normal waveform"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical scenario points to a diagnosis of <strong>atrial fibrillation</strong> and the JVP finding seen would be <strong>absent a wave</strong>.</p>\n<p>Atrial fibrillation is the most common sustained arrhythmia. There is rapid and irregular atrial activation which is transmitted through the atrioventricular node. The conducted ventricular rate is usually rapid and <strong>irregularly irregular</strong>. It can vary from <strong>110-160</strong> beats/minute. A <strong>pulse deficit</strong> is an important clinical finding associated with the condition. This arises due to preload reduction.&nbsp;</p>\n<p>Symptoms include<strong> palpitations</strong>, fatigue, presyncope, and dyspnea. An ECG shows the<strong> absence</strong> of<strong> P waves</strong>.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9c5ed9fcd3f249ff978d35cdf111c563x918x523.JPEG\" alt=\"Explanation Image\"><p>In acute atrial fibrillation with hemodynamic instability, electrical or chemical <strong>cardioversion</strong> is the first step. The latter is done by intravenous administration of class III antiarrhythmic - <strong>ibutilide</strong>. In a stable patient, <strong>ventricular rate control</strong> is the primary aim. This is done by intravenous or oral administration of <strong>beta-blockers</strong>. <strong>Calcium channel blockers</strong> such as verapamil and diltiazem can also be used.&nbsp;</p>\n<p>If the current episode duration is <strong>&gt;48 hours</strong>, cardioversion can precipitate thromboembolic complications. In such cases, cardioversion should be carried out only after <strong>3 weeks</strong> of anticoagulation. It has to be continued for 4 weeks after cardioversion. Another option is to evaluate the presence of a thrombus in the left atrial appendage. This can be done either by transesophageal echocardiography (TEE) or high-resolution CT.</p>\n<p>If the duration is &lt;48 hours and there are no high-risk factors, cardioversion can be done. <strong>The CHA2DS2-VASc</strong> scoring system is used to assess stroke risk.&nbsp;</p>\n<p><strong>Warfarin</strong> is recommended in patients with rheumatic<strong> mitral stenosis</strong> or mechanical heart valves who present with atrial fibrillation. In mitral stenosis, thrombi arise frequently from the <strong>dilated left atrium</strong>. Atrial fibrillation in the absence of mitral stenosis is known as nonvalvular atrial fibrillation. <strong>Oral factor Xa inhibitors</strong> such as apixaban, edoxaban, or rivaroxaban can be used in such cases.&nbsp;</p>\n<p>Other options:</p>\n<p>Option A: <strong>Absent p wave</strong>&nbsp;is an <strong>ECG finding</strong> seen in sinoatrial nodal disease and atrial fibrillation.&nbsp;</p>\n<p>Option C: <strong>Cannon a wave</strong> is seen in <strong>atrioventricular dissociation</strong> and contraction of the right atria against a closed tricuspid valve.</p>\n<p>Option D: <strong>Raised JVP</strong> with <strong>normal waveform</strong> is seen in conditions such as congestive heart failure, right ventricular infarction, and superior vena cava obstruction.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: JVP waveform and the abnormalities</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/18bbe4a977c84587903e8637a0d9303cx1280x1005.JPEG\" alt=\"Pearl Image\"><p>1) The <strong>a-wave</strong> corresponds to <strong>atrial contraction</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prominent a-waves</strong></td>\n<td>Pulmonary hypertension, right atrial thrombus/ mass, and tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Cannon a-waves</strong></td>\n<td>\n<p>Complete AV block, ventricular tachycardia, and premature atrial/ junctional/ ventricular beats</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent a-waves</strong></td>\n<td>Atrial fibrillation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>2) The <strong>c-wave</strong> corresponds to the <strong>bulging of tricuspid valve</strong> into right atrium during ventricular contraction.</p>\n<p>&nbsp;</p>\n<p>3) The <strong>x-descent</strong> corresponds to <strong>atrial relaxation</strong> during atrial diastole.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Absent x-descent</strong></td>\n<td>Severe tricuspid regurgitation</td>\n</tr>\n<tr>\n<td><strong>Rapid x-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>4) The <strong>v-wave</strong> corresponds to the <strong>venous filling</strong> of right atrium.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Dominant v-waves</strong></td>\n<td>Tricuspid regurgitation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>5) The <strong>y-descent</strong> corresponds to the&nbsp;<strong>passive emptying of the right atrium</strong> into right ventricle.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Conditions</strong></td>\n</tr>\n<tr>\n<td><strong>Prolonged y-descent</strong></td>\n<td>Tricuspid stenosis</td>\n</tr>\n<tr>\n<td><strong>Rapid y-descent</strong></td>\n<td>\n<p>Constrictive pericarditis and isolated severe tricuspid regurgitation</p>\n</td>\n</tr>\n<tr>\n<td><strong>Absent y-descent</strong></td>\n<td>Cardiac tamponade</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Supraventricular tachycardias</h3><p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with narrow QRS complex:</strong></p>\n<ul>\n<li><strong>Narrow QRS with regular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp; &nbsp;Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Sinus tachycardia</strong></td>\n<td>Normal P wave, normal ECG features except for the rate</td>\n</tr>\n<tr>\n<td><strong>Focal atrial tachycardia</strong></td>\n<td>A single type of abnormal p wave morphology is seen</td>\n</tr>\n<tr>\n<td><strong>Junctional tachycardia</strong></td>\n<td>No p waves. Heart rate is 100- 200/ min</td>\n</tr>\n<tr>\n<td><strong>AV nodal reentry tachycardia</strong></td>\n<td>No p waves. Pseudo R' waves may be seen. Heart rate is 150-250/ min</td>\n</tr>\n<tr>\n<td><strong>Atrioventricular reentry tachycardia</strong></td>\n<td>P wave always follows QRS. RP interval&lt; PR interval</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter</strong></td>\n<td>Sawtooth shaped flutter waves are seen</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<ul>\n<li><strong>Narrow QRS with irregular RR interval</strong></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>&nbsp; &nbsp; &nbsp;<strong>Tachycardia</strong></td>\n<td><strong>&nbsp; &nbsp; &nbsp; &nbsp;ECG features</strong></td>\n</tr>\n<tr>\n<td><strong>Atrial fibrillation</strong></td>\n<td>No distinct p waves seen</td>\n</tr>\n<tr>\n<td><strong>Multifocal atrial tachycardia</strong></td>\n<td>More than 3 different abnormal p wave morphologies are seen</td>\n</tr>\n<tr>\n<td><strong>Atrial flutter/tachycardia with variable block</strong></td>\n<td>ECG features of heart block are seen.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Supraventricular tachycardias with wide QRS complex:</strong></p>\n<ul>\n<li>Antidromic AVRT (atrioventricular reentry tachycardia)</li>\n<li>Supraventricular tachycardias with bundle branch block</li>\n</ul><hr><h3>Related Pearl: CHA2DS2-VASC scoring for risk of stroke  & need for oral anticoagulation in AF</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Components</strong></p>\n</td>\n<td>\n<p><strong>Points</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>C &ndash; Congestive heart failure</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>H - Hypertension</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A &ndash; Age &gt; 75 years</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>D &ndash; Diabetes Mellitus</p>\n</td>\n<td>\n<p>1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>S &ndash; Stroke/TIA/TE</p>\n</td>\n<td>\n<p>2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">VASc-Vascular disease (prior MI, Peripheral Arterial Disease,</p>\n<p class=\"p1\">or aortic plaque)</p>\n</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td>&nbsp;A- Age 65&ndash;74 years</td>\n<td>&nbsp;1</td>\n</tr>\n<tr>\n<td>&nbsp;S- sex category (i.e., female sex)</td>\n<td>&nbsp;1</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"p1\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>CHADS2 score</strong></p>\n</td>\n<td>\n<p><strong>Antithrombotics </strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>0</p>\n</td>\n<td>\n<p>Aspirin or no antithrombotics</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Aspirin or oral anticoagulant</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&gt;1</p>\n</td>\n<td>\n<p>Oral anticoagulant</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5394",
      "difficulty": "medium"
    },
    {
      "text": "A patient with a history of chronic liver disease presents with abdominal distension, jaundice, and pruritis. Ascitic fluid analysis revealed neutrophil count > 650 per cubic mm. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Spontaneous bacterial peritonitis"
        },
        {
          "id": 2,
          "text": "Malignant ascites"
        },
        {
          "id": 3,
          "text": "Tubercular ascites"
        },
        {
          "id": 4,
          "text": "Intestinal obstruction"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the given scenario and image of a patient with abdominal distension, jaundice, pruritus, and neutrophil count &gt;650 per mm<sup>3</sup>, the likely diagnosis is <strong>spontaneous bacterial peritonitis.&nbsp;&nbsp;</strong></p>\n<p>Spontaneous bacterial peritonitis (SBP) is an acute bacterial infection of the ascitic fluid. It is commonly seen in adults in association with liver cirrhosis. The pathogens involved are<em>&nbsp;<strong>Escherichia coli</strong>,&nbsp;</em>streptococci, enterococci, and pneumococci.&nbsp;</p>\n<p>In a patient with ascites, SBP presents with fever, and acute abdominal pain. On examination, tachycardia, tachypnea, and signs of peritonitis are seen. Hepatic encephalopathy and gastrointestinal bleeding may also occur.&nbsp;</p>\n<p>Diagnosis is by <strong>paracentesis, </strong>and an ascitic fluid <strong>neutrophil count of &gt;250/mm<sup>3</sup> </strong>is suggestive of spontaneous bacterial peritonitis. Ascitic fluid culture may reveal the pathogenic organisms.</p>\n<p>Management is mainly by <strong>third-generation cephalosporins</strong> such as cefotaxime. Albumin infusion can be given as it decreases the risk of renal failure and improves patient survival. Early diagnosis and treatment improve the prognosis.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Malignant ascites</strong> occurs as a complication of intrabdominal and extraabdominal malignancies.&nbsp;Patients can present with increasing abdominal girth, generalized abdominal pain, and shortness of breath. Weight loss may be more common. Ascitic fluid analysis reveals a <strong>milky </strong>or<strong> bloody</strong> appearance with <strong>elevated</strong> levels of<strong> tumor markers</strong> and<strong> VEGF</strong> (vascular endothelial growth factor). Treatment is by <strong>paracentesis</strong> and <strong>peritoneovenous shunt.</strong></p>\n<p>Option C: <strong>Ascites </strong>are&nbsp;often seen in patients with tubercular peritonitis. Multiple tubercles are seen on the peritoneum. Ascitic fluid analysis reveals a <strong>straw-colored fluid</strong> with a <strong>white blood cell count &gt;500/mm<sup>3</sup></strong>. Laparoscopy and peritoneal biopsy may be helpful in diagnosis. Management is by supportive and anti-tubercular therapy. &nbsp;</p>\n<p>Option D:<strong> Intestinal obstruction</strong>&nbsp;can present as pain, abdominal distension, <strong>vomiting</strong>, and <strong>absolute constipation</strong>. Abdominal radiographs taken in a supine position are useful in diagnosis. Abdominal <strong>radiograph</strong> in erect posture shows <strong>fluid levels</strong>. Management is mainly by insertion of a nasogastric tube, replacement of fluid and electrolytes, and surgery.&nbsp;</p><hr><h3>Related Pearl: Serum Ascites Albumin Gradient  (SAAG)</h3><p>The serum ascites albumin gradient is calculated as follows:</p>\n<p>SAAG = Serum albumin - Ascitic fluid albumin</p>\n<p>It can be used to determine the cause of ascites following ascitic fluid analysis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/08ad7499e5e74b398f3c98a430c6af02x1200x1361.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/13fe9c6590c14fe6aeaabdabed73dd99.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5410",
      "difficulty": "easy"
    },
    {
      "text": "Laboratory investigations of a patient being evaluated for jaundice show elevated bilirubin and alkaline phosphatase levels. Levels of the remaining liver enzymes are normal. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Obstructive jaundice"
        },
        {
          "id": 2,
          "text": "Hemolytic jaundice"
        },
        {
          "id": 3,
          "text": "Hepatic jaundice"
        },
        {
          "id": 4,
          "text": "Prehepatic jaundice"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given laboratory reports showing <strong>elevated alkaline phosphatase</strong> and <strong>bilirubin</strong> points to a likely diagnosis of <strong>obstructive jaundice</strong>.</p>\n<p>Obstructive jaundice arises due to an obstruction in the <strong>biliary outflow&nbsp;</strong>due to&nbsp;<strong>choledocholithiasis</strong>, cholelithiasis, biliary strictures, etc. The patient presents with<strong>&nbsp;jaundice</strong>,&nbsp;right upper quadrant pain,&nbsp;<strong>pruritus</strong>, <strong>dark</strong> urine, and <strong>light-colored</strong> stools. The symptoms can be <strong>intermittent</strong>&nbsp;in cases of <strong>periampullary carcinoma&nbsp;</strong>and cholangiocarcinoma.&nbsp;</p>\n<p>Elevated <strong>conjugated bilirubin</strong> and<strong> alkaline phosphatase</strong> (ALP) are characteristic of the condition.&nbsp;An associated rise in <strong>gamma-glutamyl transpeptidase</strong> (GGT) levels confirms the <strong>hepatic</strong> origin of ALP.</p>\n<p>An <strong>ultrasound</strong> is done initially in suspected cases of obstructive jaundice. A CT or <strong>magnetic resonance cholangiopancreatography</strong> (MRCP) is recommended next. <strong>Endoscopic retrograde cholangiopancreatography</strong> (ERCP) is considered the<strong> gold standard</strong> for choledocholithiasis.</p>\n<p>Jaundice arises due to the deposition of bilirubin in the body tissues.&nbsp;Bilirubin is a breakdown product of <strong>heme</strong> that circulates in the blood in the unconjugated/ <strong>indirect</strong> form. In the hepatocytes, it is conjugated with glucuronic acid to form conjugated/ <strong>direct</strong> bilirubin. Direct and indirect bilirubin can be assessed using <strong>Van den Bergh reaction</strong>.</p>\n<p>Jaundice is broadly classified into:</p>\n<ul>\n<li>Pre-hepatic jaundice</li>\n<li>Hepatic jaundice</li>\n<li>Posthepatic jaundice</li>\n</ul>\n<p>Other options:</p>\n<p>Options B and D: <strong>Hemolytic jaundice</strong> is one of the common causes of <strong>prehepatic jaundice</strong>. These include sickle cell anemia, spherocytosis, and thalassemia. Inherited enzyme disorders, such as Gilbert's syndrome, and Crigler-Najjar types I and II, are other causes. In these cases, there is an <strong>isolated elevation</strong> of <strong>unconjugated</strong>&nbsp;<strong>bilirubin</strong>.</p>\n<p>Option C: <strong>Hepatic jaundice</strong> shows an elevation of&nbsp;aspartate transaminase (<strong>AST</strong>) and&nbsp;alaline transaminase (<strong>ALT</strong>) out of proportion to ALP. An increased bilirubin level is also seen. Common causes include viral hepatitis, alcoholic liver disease, and autoimmune hepatitis. An <strong>AST/ALT ratio&nbsp;&ge; 2</strong> is highly suggestive of <strong>alcoholic hepatitis</strong>.</p><hr><h3>Related Pearl: Types of Jaundice</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of jaundice</strong></td>\n<td><strong>Serum bilirubin</strong></td>\n<td><strong>Urine Urobilinogen</strong></td>\n<td><strong>Urine bilirubin</strong></td>\n</tr>\n<tr>\n<td>Pre-hepatic</td>\n<td>&uarr; Indirect</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;-</td>\n</tr>\n<tr>\n<td>Hepatic</td>\n<td>&uarr; Direct and indirect</td>\n<td>&nbsp; Normal/&nbsp;&darr;</td>\n<td>&nbsp; &nbsp; &nbsp; +/-</td>\n</tr>\n<tr>\n<td>Post-hepatic</td>\n<td>&uarr; Direct</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;-</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;+</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Hyperbilirubinemia- Causes</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Predominantly Unconjugated Hyperbilirubinemia&nbsp;</strong></td>\n<td><strong>Conjugated hyperbilirubinemia</strong></td>\n</tr>\n<tr>\n<td>\n<p>Excess production of bilirubin</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hemolytic anemias</p>\n</td>\n<td>\n<p>Biliary tract obstruction</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Resorption of blood from internal hemorrhage (e.g., alimentary tract bleeding, hematomas)</p>\n</td>\n<td>\n<p>&nbsp;Biliary tract diseases like primary biliary cirrhosis and primary sclerosing cholangitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ineffective erythropoiesis (e.g., pernicious anemia, thalassemia)</p>\n</td>\n<td>\n<p>Dubin Johnson syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reduced hepatic uptake</p>\n</td>\n<td>\n<p>Rotor syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Drug interference with membrane carrier systems</p>\n</td>\n<td>Benign recurrent intrahepatic cholestasis</td>\n</tr>\n<tr>\n<td>\n<p>Some cases of Gilbert syndrome</p>\n</td>\n<td>Progressive familial intrahepatic cholestasis</td>\n</tr>\n<tr>\n<td>\n<p>Impaired bilirubin conjugation</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Physiologic jaundice of the newborn (decreased UGT1A1 activity, decreased excretion)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Breast milk jaundice (&beta;-glucuronidases in milk)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Genetic deficiency of UGT1A1 activity (Crigler-Najjar syndrome types I and II)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse hepatocellular disease (e.g., viral or drug-induced hepatitis, cirrhosis)</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Hereditary Hyperbilirubinemias</h3><table>\n<tbody>\n<tr>\n<td><strong>Disorder</strong></td>\n<td><strong>Inheritance</strong></td>\n<td><strong>Defects in bilirubin metabolism</strong></td>\n<td><strong>Clinical course</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>Unconjugated Hyperbilirubinemia</strong></p>\n</td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type I</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Absent UGT1A1 activity</p>\n</td>\n<td>\n<p>Fatal in the neonatal period</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crigler-Najjar syndrome type II</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Generally mild,</p>\n<p>occasional kernicterus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gilbert syndrome</p>\n</td>\n<td>\n<p>AR (common)</p>\n<p>AD (occasional)</p>\n</td>\n<td>\n<p>Decreased UGT1A1 activity</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Conjugated Hyperbilirubinemia</strong></p>\n</td>\n<td> </td>\n<td> </td>\n<td> </td>\n</tr>\n<tr>\n<td>\n<p>Dubin-Johnson syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Impaired biliary excretion of bilirubin glucuronides due to a mutation in canalicular multidrug resistance protein 2 (MRP2)</p>\n</td>\n<td>\n<p>Innocuous with black pigmentation of liver</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Rotor syndrome</p>\n</td>\n<td>\n<p>AR</p>\n</td>\n<td>\n<p>Decreased hepatic uptake and storage</p>\n<p>Decreased biliary excretion</p>\n</td>\n<td>\n<p>Innocuous</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5422",
      "difficulty": "medium"
    },
    {
      "text": "A woman presents to you with fever, arthralgia, ulcers, fatigue for the past six months, and new-onset hematuria.  Urine examination reveals RBC casts and proteinuria. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Acute interstitial nephritis"
        },
        {
          "id": 2,
          "text": "Poststreptococcal glomerulonephritis"
        },
        {
          "id": 3,
          "text": "Lupus nephritis"
        },
        {
          "id": 4,
          "text": "IgA nephropathy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The above clinical scenario points to a diagnosis of <strong>lupus nephritis</strong>.</p>\n<p>Lupus nephritis is a common complication of systemic lupus erythematosus (SLE). It results from immune <strong>complex deposition</strong> containing DNA and anti-DNA.&nbsp;Clinical features include <strong>proteinuria</strong>, <strong>hematuria</strong>, and hypertension. The disease is divided into 6 classes based on the severity. Patients with class V disease are at an increased risk of <strong>thrombotic complications</strong>. Lupus nephritis can result in end-stage disease warranting dialysis or transplantation.</p>\n<p>SLE is an autoimmune condition more commonly seen in women. Antinuclear antibodies, anti-dsDNA, and anti-Sm are the autoantibodies implicated. Symptoms include maculopapular <strong>butterfly rash</strong>, <strong>photosensitivity</strong>, oral or nasal ulcers, fever, and intermittent <strong>polyarthritis</strong>. Pleuritis and pericarditis can also be associated. <strong>Systemic glucocorticoids</strong>, cyclophosphamide, or mycophenolate mofetil are used for management. Due to the possible teratogenic effects of these drugs, <strong>hydroxychloroquine</strong> is the mainstay in <strong>pregnancy</strong>.</p>\n<p>Other options:</p>\n<p>Option A - <strong>Acute interstitial nephritis</strong> is a type of acute kidney injury. It is marked by <strong>oliguria</strong> and raised creatinine. Various causes of interstitial injury include the use of <strong>non-steroidal anti-inflammatory drugs</strong> (NSAIDs), pyelonephritis, leukemia, and sepsis. <strong>White blood cell</strong> (WBC)<strong>&nbsp;casts</strong> and <strong>granular</strong> casts may be seen.</p>\n<p>Option B - <strong>Post-streptococcal glomerulonephritis</strong> usually affects <strong>male children</strong> between the age of 2-14. Skin or <strong>pharyngeal</strong> infection with M types of the organism is implicated. Symptoms include <strong>hematuria</strong>, <strong>pyuria</strong>, and hypertension. Flank pain and headache are also associated symptoms. <strong>Red blood cell</strong> (RBC) <strong>casts</strong> are seen in the urine.</p>\n<p>Option D - <strong>IgA nephropathy</strong> arises due to mesangial IgA deposition. It is characterized by recurrent <strong>macroscopic hematuria</strong> after an upper respiratory infection associated with proteinuria. <strong>Mesangial proliferation</strong> is a distinctive feature. Angiotensin-converting enzyme (ACE) inhibitors and steroids can be used for management.</p><hr><h3>Related Pearl: Classification of Lupus Nephritis (International Society of Nephrology and Renal Pathology Society)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Class&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>Findings</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal mesangial lupus nephritis (class I)</p>\n</td>\n<td>\n<p><strong>Immune complex deposition</strong> in&nbsp;the mesangium without structural changes by light microscopy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mesangial proliferative lupus nephritis (class II)</p>\n</td>\n<td>\n<p><strong>Mesangial cell proliferation</strong> with mesangial immune deposits</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Focal lupus nephritis (class III)</p>\n</td>\n<td>\n<p>Focal, segmental <strong>glomerulonephritis</strong> involving <strong>less than 50%</strong> of all glomeruli.</p>\n<p>Focal subendothelial deposits with or without mesangial changes</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse lupus nephritis (class IV)</p>\n</td>\n<td>\n<p>The most common and severe form of lupus nephritis</p>\n<p>Diffuse&nbsp;<strong>glomerulonephritis</strong> involving <strong>more than 50%</strong> of all glomeruli</p>\n<p>Diffuse subendothelial deposits with or without mesangial changes<strong>. &ldquo;Wire loop&rdquo;</strong> structures on light microscopy.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous lupus nephritis (class V)</p>\n</td>\n<td>\n<p>Global or segmental&nbsp;<strong>subepithelial</strong> immune deposits with or without mesangial proliferation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Advanced sclerosing lupus nephritis (class VI)</p>\n</td>\n<td>\n<p><strong>Sclerosis</strong> of <strong>more than 90%</strong> of the glomeruli&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>Focal- Involves only a few glomeruli</li>\n<li>Diffuse- Involves almost all the glomeruli</li>\n<li>Segmental- Involves only a part of glomerulus</li>\n<li>Global- Involves entire glomerulus</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b83e16725c9e4acbae2e0ff8275ec1a5x1279x911.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Characteristic Findings in Systemic Lupus Erythematosus (SLE)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>System</strong></p>\n</td>\n<td>\n<p><strong>Characteristic findings</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Blood Vessels</p>\n</td>\n<td>\n<p>Acute necrotizing vasculitis with fibrinoid necrosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidney</p>\n</td>\n<td>\n<p><strong>\"Wire-loop\" lesions</strong></p>\n<p>Tubulointerstitial lesions</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Vacuolar degeneration of the basal layer of the epidermis</p>\n<p><strong>Vasculitis with fibrinoid necrosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Joints</p>\n</td>\n<td>\n<p><strong>Non-erosive arthritis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiovascular system</p>\n</td>\n<td>\n<p>Fibrinous pericarditis</p>\n<p><strong>Libman&ndash;Sacks endocarditis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Spleen</p>\n</td>\n<td>\n<p>Splenomegaly</p>\n<p>Capsular thickening</p>\n<p>Follicular hyperplasia</p>\n<p><strong>Onion-skin lesions of arteries</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lungs</p>\n</td>\n<td>\n<p>Pleuritis, pleural effusion, chronic interstitial fibrosis and secondary pulmonary hypertension</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bone marrow</p>\n</td>\n<td>\n<p><strong>Hematoxylin bodies</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lymph nodes</p>\n</td>\n<td>\n<p>Lymphadenopathy with hyperplastic follicles</p>\n<p>Necrotizing lymphadenitis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>The image below shows</strong>&nbsp;<strong>hematoxylin bodies in systemic lupus erythematosus (SLE)-associated lymphadenopathy.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1da1c0f61e29410c9f97bd2143e58b53x1280x1052.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Antibodies in Systemic lupus erythematosus (SLE)</h3><table>\n<tbody>\n<tr>\n<td><strong>Antibody</strong></td>\n<td><strong>Prevelance %</strong></td>\n<td><strong>Antigen Recognized</strong></td>\n<td><strong>Clinical utility</strong></td>\n</tr>\n<tr>\n<td>Antinuclear Antibody</td>\n<td>98</td>\n<td>Multiple nuclear</td>\n<td>Best screening test; repeated -ve test make SLE unlikely</td>\n</tr>\n<tr>\n<td>Anti dS-DNA</td>\n<td>70</td>\n<td>DNA(double stranded)</td>\n<td>High titres are SLE specific &amp; in some patients correlates  with disease activity, nephritis &amp; vasculitis</td>\n</tr>\n<tr>\n<td>Anti-Sm</td>\n<td>25</td>\n<td>Protein complexed to 6 species of nuclear U1 RNA</td>\n<td>Specific for SLE; no definite correlations; most patients also have anti RNP <br />More common in black &amp; asians than white</td>\n</tr>\n<tr>\n<td>Anti-RNP</td>\n<td>40</td>\n<td>Protein complexed to U1 RNA</td>\n<td>Not Specific for SLE; high titre associated with syndromes that have overlap features of several rheumatic syndromes including SLE;<br />More common in blacks and whites </td>\n</tr>\n<tr>\n<td>Anti-Ro( SS-A)</td>\n<td>30</td>\n<td>Protein complexed to hY RNA,<br />Primarily 60kDA and 52kDA</td>\n<td>Not Specific for SLE; associated with sicca syndrome, predisposes to subacute cutaneous lupus &amp; to neonatal lupus with congenital heart block; associated with decrease risk of nephritis</td>\n</tr>\n<tr>\n<td>Anti-La( SS-B)</td>\n<td>10</td>\n<td>47kDa protein complexed to hY RNA</td>\n<td>Usually associated with anti-RO, associated with decreased  risk for nephritis</td>\n</tr>\n<tr>\n<td>Antihistone</td>\n<td>70</td>\n<td>Histones associated with DNA<br />(In nucleosome &amp; chromatin)</td>\n<td>More frequent in drug induced lupus than in SLE</td>\n</tr>\n<tr>\n<td>Antiphospholipid</td>\n<td>50</td>\n<td>Phospholipid,β2 glycoprotein1(β2 G1) cofactor , prothrombin</td>\n<td>3 tests available-ELISAs for cardiolipin &amp; β2 G1,<br />Sensitive prothrombin time (DRVVT)<br />Predisposes to clotting, fetal loss, thrombocytopenia</td>\n</tr>\n<tr>\n<td>Antierythrocyte</td>\n<td>60</td>\n<td>Erythrocyte membrane </td>\n<td> Measured as direct Coombs test , a small proportion devlop overt hemolysis</td>\n</tr>\n<tr>\n<td>Antiplatelet</td>\n<td>30</td>\n<td>Surface &amp; altered cytoplasmic antigens on platelets</td>\n<td>Associated with thrombocytopenia, but sensitivity &amp; specificity are not good:<br />This is not a useful clinical test</td>\n</tr>\n<tr>\n<td>Antineuronal<br />(includes antiglutamate receptor)</td>\n<td>60</td>\n<td>Neuronal &amp; lymphocyte surface antigens</td>\n<td>In some series, a positive test in CSF correlates with active CNS lupus</td>\n</tr>\n<tr>\n<td>Antiribosomal P</td>\n<td>20</td>\n<td>Protein in ribosomes</td>\n<td>In some series, a positive test serum correlates with depression or psychosis due to CNS lupus</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5360",
      "difficulty": "medium"
    },
    {
      "text": "An 11-year-old child with a history of streptococcal pharyngitis presents you with fever and arthralgia. There is no past history of rheumatic heart disease or features of carditis or valvular disease. How often is 6,00,000 IU of benzathine penicillin recommended for prophylaxis of rheumatic heart disease?",
      "choices": [
        {
          "id": 1,
          "text": "Immediately"
        },
        {
          "id": 2,
          "text": "Thrice weekly lifelong"
        },
        {
          "id": 3,
          "text": "Once in three weeks for 5 years or till the age of 18, whichever is longer"
        },
        {
          "id": 4,
          "text": "Once in three weeks for 10 years or till the age of 25, whichever is longer"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario points to a diagnosis of <strong>acute rheumatic fever</strong> (ARF). The secondary prophylaxis after an episode for a patient weighing &lt;27 kilograms is <strong>6,00,000 IU </strong>of<strong> benzathine penicillin </strong>injection<strong>&nbsp;once every three weeks&nbsp;</strong>for <strong>5 years </strong>or<strong> till the age of 18</strong>, whichever is <strong>longer.</strong></p>\n<p>ARF is an autoimmune disease that develops in response to <strong>group A streptococcal</strong> infection. It is commonly seen in children between the age of <strong>5-14 </strong>years. An upper respiratory tract infection with some <strong>M serotypes</strong> of the organism is the trigger. The concept of <strong>molecular mimicry</strong> is used to explain the pathogenesis of the condition.&nbsp;</p>\n<p>Since one attack of ARF increases the risk for further episodes and development of RHD, <strong>secondary prophylaxis</strong> is recommended by the American heart association (AHA) as follows:</p>\n<ul>\n<li>Rheumatic fever <strong>without carditis</strong>: For<strong> 5 years</strong> after the last attack or <strong>till 18/21</strong> years of age (whichever is longer).&nbsp;</li>\n<li>Rheumatic fever <strong>with carditis</strong> but <strong>no</strong> residual<strong> valvular disease</strong>: For <strong>10 years</strong> after the last attack or <strong>till 21/25</strong> years of age (whichever is longer).</li>\n<li>Rheumatic fever with <strong>persistent valvular disease</strong>, evident clinically or on echocardiography: For <strong>10 years</strong> after the last attack or <strong>till</strong> the age of <strong>40</strong> (whichever is longer). Sometimes <strong>lifelong</strong> prophylaxis can be given.</li>\n</ul>\n<p>Symptoms usually present after a latent period of about three weeks. Indolent carditis and chorea are the exceptions that can present even six months later. <strong>Migratory asymmetric polyarthritis</strong>&nbsp;which affects large joints and <strong>high-grade fever</strong> are common features. Cutaneous manifestations include <strong>erythema marginatum</strong>&nbsp;and <strong>subcutaneous nodules</strong>.<strong>&nbsp;Sydenham's chorea</strong> is commonly found in <strong>females</strong> and frequently affects the head and upper limbs. Acute rheumatic carditis can be seen as involvement of the endocardium, myocardium, or pericardium. Histopathological examination shows <strong>Aschoff bodies</strong>&nbsp;and activated macrophages called <strong>Anitschkow cells</strong>.</p>\n<p>The image below shows Aschoff bodies.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c2cf31e7fe7f4aa3b0784289ccc98285x1280x853.JPEG\" alt=\"Explanation Image\"><p>In chronic rheumatic heart disease, there is a leaflet and tendinous cord thickening along with commissural fusion and shortening of the mitral valve. Ultimately the valve can undergo <strong>stenotic changes</strong> giving it a<strong> fish-mouth appearance</strong> as shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1a94028a01d341199577fa091b855316x1189x703.JPEG\" alt=\"Explanation Image\"><p>The <strong>modified</strong> <strong>Jones criteria</strong> is used for diagnosis. Management of ARF is mainly symptomatic by the use of antibiotics and NSAIDs.</p><hr><h3>Related Pearl: Revised Jones criteria for diagnosis of Acute Rheumatic Fever (ARF)</h3><p>Revised Jones criteria for the diagnosis of rheumatic fever are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">Major criteria</td>\n</tr>\n<tr>\n<td><strong>Low-risk populations*</strong></td>\n<td><strong>Moderate- and high-risk populations*</strong></td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Carditis- Clinical or subclinical</td>\n<td>Carditis- Clinical or subclinical</td>\n</tr>\n<tr>\n<td>Arthritis- <strong>Polyarthritis only</strong></td>\n<td>Arthritis- <strong>P</strong><strong>olyarthritis/polyarthralgia/monoarthritis</strong></td>\n</tr>\n<tr>\n<td>Chorea</td>\n<td>Chorea</td>\n</tr>\n<tr>\n<td>Erythema marginatum</td>\n<td>Erythema marginatum</td>\n</tr>\n<tr>\n<td>Subcutaneous nodules</td>\n<td>Subcutaneous nodules</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td colspan=\"2\">Minor criteria&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Polyarthralgia</strong></td>\n<td><strong>Monoarthralgia</strong></td>\n</tr>\n<tr>\n<td>Fever&nbsp;(&ge;38.5&deg;C)</td>\n<td>Fever (&ge;38&deg;C)</td>\n</tr>\n<tr>\n<td>ESR &ge;60 mm in the first hour and/or CRP &ge;3.0 mg/dL</td>\n<td>ESR &ge;30 mm/hr and/or CRP &ge;3.0 mg/dL</td>\n</tr>\n<tr>\n<td><strong>Prolonged PR interval</strong>, after accounting for age variability (unless carditis is a major criterion)</td>\n<td>Prolonged PR interval, after accounting for age variability (unless carditis is a major criterion)&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td colspan=\"2\">For all patient populations with evidence of preceding Group A Streptococcal infection:(Increased ASLO/ anti-DNAse B titer or positive throat culture for group A streptococcus or positive rapid streptococcal carbohydrate antigen test)&nbsp;</td>\n</tr>\n<tr>\n<td>Diagnosis of initial ARF</td>\n<td>2 Major criteria or 1 major plus 2 minor criteria</td>\n</tr>\n<tr>\n<td>Diagnosis of recurrent ARF</td>\n<td>2 Major or 1 major and 2 minor or 3 minor criteria</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Low-risk populations are those with ARF incidence &le;2 per 100&thinsp;000 school-aged children or all-age rheumatic heart disease prevalence of &le;1 per 1000 population per year. If the incidence exceeds the given limit, then it is moderate-high risk populations.</p><hr><h3>Related Pearl: Named Cells in Histopathology</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Named cells</strong></p>\n</td>\n<td>\n<p><strong>Condition</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anitschkow or caterpillar cells</p>\n</td>\n<td>\n<p>Rheumatic heart disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Globoid cells</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kulchitsky cells</p>\n</td>\n<td>\n<p>Small cell carcinoma of lung</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Signet ring cells</p>\n</td>\n<td>\n<p>Signet ring cell carcinoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Crumpled tissue paper macrophages</p>\n</td>\n<td>\n<p>Gauchers disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Clue cells</p>\n</td>\n<td>\n<p>Bacterial vaginosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fried egg cells</p>\n</td>\n<td>\n<p>Oligodendroglioma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hallmark cells</p>\n</td>\n<td>\n<p>Anaplastic large cell lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Shadow cells</p>\n</td>\n<td>\n<p>Pilomatricoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mott cells</p>\n</td>\n<td>\n<p>Plasma cell myeloma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Lepidic cells</p>\n</td>\n<td>\n<p>Cardiac myxoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Spider cells</p>\n</td>\n<td>\n<p>Rhabdomyoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Vegetations in Various Types of Endocarditis</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>RHD</strong></p>\n</td>\n<td>\n<p><strong>Infective endocarditis</strong></p>\n</td>\n<td>\n<p><strong>Non- bacterial thrombotic or marantic endocarditis</strong></p>\n</td>\n<td>\n<p><strong>Libman&ndash;Sacks endocarditis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Etiology</strong></p>\n</td>\n<td>\n<p>Rheumatic</p>\n<p>heart disease</p>\n</td>\n<td>\n<p>Infective endocarditis</p>\n</td>\n<td>\n<p>Malignancy</p>\n<p>(M3-AML, pancreatic</p>\n<p>carcinoma), deep</p>\n<p>vein thrombosis,</p>\n<p>Trosseau syndrome</p>\n</td>\n<td>\n<p>Systemic lupus erythematosus</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Vegetations</strong></p>\n</td>\n<td>\n<p>Small, warty</p>\n<p>Firm</p>\n<p>Friable</p>\n</td>\n<td>\n<p>Large</p>\n<p>Bulky</p>\n<p>friable,</p>\n<p>destructive</p>\n</td>\n<td>\n<p>Small, single or multiple, non- destructive</p>\n</td>\n<td>\n<p>Small to medium-sized, flat, verrucuous</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Site</strong></p>\n</td>\n<td>\n<p>Along lines of closure</p>\n</td>\n<td>\n<p>Cusps of valves, mural endocardium</p>\n</td>\n<td>\n<p>Line of closure</p>\n</td>\n<td>\n<p>Either or</p>\n<p>both sides of the valve leaflets.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Sterile/Infective</strong></p>\n</td>\n<td>\n<p>Sterile</p>\n</td>\n<td>\n<p>Non-sterile</p>\n</td>\n<td>\n<p>Sterile</p>\n</td>\n<td>\n<p>Sterile</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Embolisation</strong></p>\n</td>\n<td>\n<p>Uncommon</p>\n</td>\n<td>\n<p>Very common</p>\n</td>\n<td>\n<p>Common</p>\n</td>\n<td>\n<p>Uncommon</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8cbba8132d2c40e08cdaa19e5a970968x1280x2262.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5361",
      "difficulty": "medium"
    },
    {
      "text": "A man on diuretics presents with weakness. An ECG was done which showed flat T waves and prominent U waves. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Hypokalemia"
        },
        {
          "id": 2,
          "text": "Hyperkalemia"
        },
        {
          "id": 3,
          "text": "Hypomagnesemia"
        },
        {
          "id": 4,
          "text": "Hypernatremia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Based on the clinical scenario, the most likely diagnosis is <strong>hypokalemia</strong>.</p>\n<p>Hypokalemia is defined as a plasma concentration of K<sup>+</sup> <strong>&lt;3.5 meq/L</strong>. Common causes include <strong>metabolic alkalosis</strong>, diarrhea, use of <strong>diuretics</strong>, starvation, and&nbsp;<strong>&beta;2-agonists</strong>. It can also be seen after massive blood transfusion and in cystic fibrosis. It affects the cardiac, skeletal, and intestinal cells. It can lead to <strong>arrhythmias</strong> and<strong> intestinal ileus</strong> and increases the risk for rhabdomyolysis.</p>\n<p>ECG changes include <strong>ST depression</strong>,<strong> prominent U waves</strong>, and prolonged repolarization. <strong>Pseudo P pulmonale</strong> waves can also be seen.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/654f9f416b3d4e08aee486963e2631d4x720x356.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a3167bba8aa2470595a26392f2bc2d43x1280x2207.JPEG\" alt=\"Explanation Image\"><p><strong>Oral potassium chloride</strong> is the mainstay in management. In patients unable to use the enteral route, intravenous potassium chloride can be given in saline.&nbsp;</p>\n<p>Other options:</p>\n<p>Option B: <strong>Hyperkalemia</strong> is a plasma K<sup>+</sup> concentration <strong>&gt;5.5 meq/L</strong>.Common causes include acidosis, the use of <strong>angiotensin-converting enzyme (ACE) inhibitors</strong>, and <strong>&beta;2-antagonists</strong>. It can be seen as a manifestation of <strong>chronic kidney disease,</strong> and after a massive blood transfusion. It leads to increased aldosterone secretion.&nbsp; ECG changes include <strong>tall T waves</strong>, prolonged PR intervals, and small P waves. In severe cases, wide QRS complexes which progress to an undulating pattern (sine wave) and asystole can be seen.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0bbf1bb180d142009818cd2cadfc56d1x1158x893.JPEG\" alt=\"Explanation Image\"><p>Option C:<strong> Hypomagnesemia</strong> can arise due to prolonged use of proton pump inhibitors. It presents as delirium, neuromuscular dysfunction, reduced parathyroid function, and treatment-resistant <strong>hypokalemia</strong>. ECG might reveal <strong>hypokalemia</strong> potentiated by the condition. It has been implicated in <strong>ventricular arrhythmias</strong> with acute myocardial infarction and<strong> torsades de pointes</strong>. It can also enhance <strong>digitalis toxicity</strong>.</p>\n<p>Option D: <strong>Hypernatremia</strong> is defined as plasma Na<sup>+</sup> concentration <strong>&gt;145 meq/L</strong>. Common causes include diarrhea, hyperglycemia, and post obstructive diuresis. <strong>Altered mental status</strong> and generalized weakness are the common manifestations. It can also cause <strong>neonatal seizures</strong>.&nbsp;</p><hr><h3>Related Pearl: Etiology of Torsade De Pointes</h3><p><strong>Acquired prolongation of QT interval</strong></p>\n<p><strong>Electrolyte abnormalities</strong></p>\n<ul>\n<li>Hypokalemia</li>\n<li>Hypomagnesemia</li>\n<li>Hypocalcemia</li>\n</ul>\n<p><strong>Drugs</strong></p>\n<ul>\n<li><strong>Antiarrhythmic drugs</strong>\n<ul>\n<li>Class IA: Quinidine, disopyramide, procainamide</li>\n<li>Class III: Sotalol, amiodarone (QT prolongation common but torsade ventricular tachycardia is rare), ibutilide, dofetilide, almokalant</li>\n</ul>\n</li>\n<li><strong>Antibiotics</strong>\n<ul>\n<li>Macrolides: Erythromycin, clarithromycin, azithromycin</li>\n<li>Fluoroquinolones: Levofloxacin, moxifloxacin, gatifloxacin</li>\n<li>Trimethoprim-sulfamethoxazole</li>\n<li>Clindamycin</li>\n<li>Pentamidine</li>\n<li>Chloroquine</li>\n<li>Antifungals: Ketoconazole, itraconazole</li>\n<li>Antivirals</li>\n<li>Antipsychotics</li>\n<li>Antihistamines</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5382",
      "difficulty": "easy"
    },
    {
      "text": "A male patient presents to the emergency department. The arterial blood gas report is as follows: pH, 7.2; pCO2, 81mm Hg; and HCO3, 40 meq/L. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Respiratory alkalosis"
        },
        {
          "id": 2,
          "text": "Metabolic acidosis"
        },
        {
          "id": 3,
          "text": "Respiratory acidosis"
        },
        {
          "id": 4,
          "text": "Metabolic alkalosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The arterial blood gas values suggest a likely diagnosis of <strong>respiratory acidosis</strong>.</p>\n<p>The various buffering systems present in the body maintain the systemic arterial pH between <strong>7.35-7.45</strong>. The most common acid-base disorders are metabolic acidosis or alkalosis and respiratory acidosis or alkalosis.</p>\n<p>Normal values in an arterial blood gas are as follows:</p>\n<ul>\n<li>pH:&nbsp;7.35-7.45</li>\n<li class=\"half_rhythm\">\n<div>PaCO<sub>2</sub>: 35-45 mmHg</div>\n</li>\n<li class=\"half_rhythm\">\n<div>HCO<sub>3</sub>: 22-26 mEq/L</div>\n</li>\n<li class=\"half_rhythm\">\n<div>PaO<sub>2</sub>: 75-100 mmHg</div>\n</li>\n</ul>\n<p>Respiratory changes (changes in PCO<sub>2</sub>) promote a corresponding change in metabolic response (changes in HCO<sup>3-</sup>) and vice versa as a <strong>compensatory mechanism</strong>. In general, PCO<sub>2</sub> and HCO<sup>3-</sup> move in the <strong>same direction</strong> for compensation in metabolic and respiratory acid-base disorders respectively. A change in the two parameters in <strong>opposite directions</strong> points to a <strong>mixed acid-base disturbance</strong>.&nbsp;</p>\n<p>Respiratory acidosis can be secondary to severe pulmonary disease, respiratory muscle fatigue, or ventilatory control abnormalities. It is marked by an <strong>increase</strong> in PaCO<sub>2</sub>&nbsp;and a <strong>decrease</strong> in<strong> pH</strong>. A compensatory <strong>rise</strong> of <strong>HCO<sup>3-</sup></strong> can also be seen.&nbsp;</p>\n<p>A rapid rise in PCO<sub>2</sub> (acute hypercapnia) can present with <strong>dyspnea</strong>, <strong>confusion</strong>, and psychosis. It can be seen in severe asthma secondary to bronchospasm, anaphylaxis, or inhalational burns. Chronic hypercapnia causes sleep disorders, memory loss, and daytime somnolence. It is commonly seen in end-stage <strong>obstructive lung disease</strong>.&nbsp;</p>\n<p>Acute respiratory acidosis may need <strong>tracheal intubation</strong> and assisted <strong>mechanical ventilation</strong>. Rapid correction of hypercapnia should be avoided as it can trigger cardiac arrhythmias and seizures. Chronic respiratory acidosis is difficult to manage and improvement in lung function is the primary aim.&nbsp;</p>\n<p>Other options:</p>\n<p>Option A: <strong>Respiratory alkalosis</strong> arises due to alveolar hyperventilation and can be due to salicylates, <strong>high altitude states</strong>,<strong> cardiac failure</strong>, and anemia.&nbsp;</p>\n<p>Option B:<strong> Metabolic acidosis</strong> arises due to an accumulation of endogenous acids. Examples include lactic acidosis, <strong>diabetic ketoacidosis</strong>, and starvation. It can also be seen in renal failure.&nbsp;</p>\n<p>Option D: <strong>Metabolic alkalosis</strong> can be seen in <strong>Liddle's syndrome</strong>, <strong>hypertrophic pyloric stenosis</strong>, massive blood transfusion, and cystic fibrosis. It is marked by elevated pH and HCO<sup>3-</sup> values. A rise in PaCO<sub>2</sub> indicates a compensatory respiratory response.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cea77858973342d1816320d43c36b6b1x1280x1555.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Expected compensation in acid-base disorders</h3><table>\n<tbody>\n<tr>\n<td>Primary disorder</td>\n<td>Expected compensation</td>\n</tr>\n<tr>\n<td>Metabolic acidosis</td>\n<td>\n<p>Expected PaCO<sub>2</sub> = [1 .5 X HCO<sub>3</sub><sup>-</sup>] + 8 &plusmn; 2; or</p>\n<p>&darr; PaCO2 = 1.25 x &Delta;HCO3</p>\n</td>\n</tr>\n<tr>\n<td>Metabolic alkalosis</td>\n<td>Increase in PaCO<sub>2 </sub>= 0.75 x &Delta;HCO<sub>3</sub><sup>-</sup></td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Respiratory acidosis</p>\n</td>\n</tr>\n<tr>\n<td>Acute</td>\n<td>\n<p>Increase in HCO<sub>3</sub><sup>- </sup>= 0.1 x &Delta; PaCO<sub>2</sub></p>\n<p>&darr; pH = 0.008 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td>Chronic</td>\n<td>\n<p>Increase in HCO<sub>3</sub><sup>- </sup>= 0.4 x &Delta; PaCO<sub>2</sub></p>\n<p>&darr; pH = 0.003 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Respiratory alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute</p>\n</td>\n<td>\n<p>Decrease in HCO<sub>3</sub><sup>- </sup>= 0.2 x &Delta; PaCO<sub>2</sub></p>\n<p>&uarr; pH = 0.008 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic</p>\n</td>\n<td>\n<p>Decrease in HCO<sub>3</sub><sup>- </sup>= 0.4 x &Delta; PaCO<sub>2</sub></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Causes of Metabolic Acidosis</h3><table>\n<tbody>\n<tr>\n<td>High Anion-Gap Metabolic Acidosis (MUDPILES)</td>\n<td>Normal Anion-Gap Metabolic Acidosis (FUSED CAR)</td>\n</tr>\n<tr>\n<td><strong>M</strong>ethanol</td>\n<td><strong>F</strong>istula pancreatic</td>\n</tr>\n<tr>\n<td><strong>U</strong>remia (Renal failure - Acute or Chronic)</td>\n<td><strong>U</strong>reterosigmoidostomy</td>\n</tr>\n<tr>\n<td><strong>D</strong>iabetic ketoacidosis</td>\n<td><strong>S</strong>mall bowel fistula</td>\n</tr>\n<tr>\n<td><strong>P</strong>araldehyde</td>\n<td><strong>E</strong>xtra chloride (Hyperalimentation)</td>\n</tr>\n<tr>\n<td><strong>I</strong>ron tablets, INH</td>\n<td><strong>D</strong>iarrhea</td>\n</tr>\n<tr>\n<td><strong>L</strong>actic acidosis</td>\n<td><strong>C</strong>arbonic anhydrase inhibitor (acetazolamide)</td>\n</tr>\n<tr>\n<td><strong>E</strong>thylene glycol</td>\n<td><strong>A</strong>ddison's disease</td>\n</tr>\n<tr>\n<td><strong>S</strong>alicylates</td>\n<td><strong>R</strong>enal tubular acidosis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Interpretation of Acid-Base Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p>pH&lt;7.35 is acidosis</p>\n<p>pH&gt;7.45 is alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in HCO<sub>3</sub><sup>-</sup> is termed metabolic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is in keeping with the pH (i.e. if there are acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is decreased) the problem is metabolic.</p>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is opposite with the pH (i.e. if there is acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is increased or normal) the problem is compensatory metabolic.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in CO<sub>2 </sub>is termed as respiratory</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in CO<sub>2 </sub>keeping in line with the pH (if in acidosis CO2 is raised) the problem is termed respiratory</p>\n<p>If the change in CO<sub>2</sub> is in the opposite direction of that of the pH (i.e. if there&nbsp;are acidosis and CO<sub>2</sub> is decreased or normal ) the problem is termed compensatory respiratory</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5415",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not seen in MEN 2B syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Megacolon"
        },
        {
          "id": 2,
          "text": "Parathyroid adenoma"
        },
        {
          "id": 3,
          "text": "Mucosal neuroma"
        },
        {
          "id": 4,
          "text": "Marfanoid habitus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Parathyroid adenoma</strong> is <strong>not</strong> seen in <strong>multiple endocrine neoplasia 2B</strong> (MEN 2B) syndrome.</p>\n<p>Multiple endocrine neoplasia (MEN) describes conditions with tumors involving <strong>two or more</strong> endocrine glands. There are four types - MEN 1-4. They have an <strong>autosomal dominant</strong> pattern of inheritance and can also be sporadic.&nbsp;</p>\n<p>MEN type 2&nbsp;comprises groups of disorders caused by gain-of-function mutations of the RET proto-oncogene at chromosomal locus 10q11.2. There are three variants:</p>\n<ul>\n<li>MEN 2A, also known as MEN 2 (most common type)</li>\n<li>MEN 2B, also known as MEN 3</li>\n<li>MTC only</li>\n</ul>\n<p>MEN<strong> 2A</strong>&nbsp;is also known as <strong>Sipple's syndrome</strong>. It is characterized by <strong>medullary thyroid carcinoma</strong> (MTC), <strong>pheochromocytomas</strong>, and <strong>parathyroid&nbsp;tumors</strong>.&nbsp;</p>\n<p>In MEN <strong>2B</strong>&nbsp;along with MTC and pheochromocytoma, it is associated with other abnormalities such as <strong>mucosal neuromas</strong>, <strong>marfanoid habitus</strong>, medullated corneal nerve fibers, and <strong>megacolon</strong>.&nbsp;Parathyroid tumors are generally not seen here, in contrast to the MEN 2A type.</p>\n<p><strong>MTC</strong>&nbsp;presents early and is usually aggressive. MTC is the most common feature, presents as a palpable mass in the neck, and can be associated with pressure symptoms. Ectopic adrenocorticotropic hormone (ACTH) secreted by the tumor can cause <strong>Cushing's syndrome</strong>.</p>\n<p><strong>Pheochromocytoma</strong>&nbsp;is frequently bilateral. Palpitations, sweating, and headaches are the features of pheochromocytoma.&nbsp;</p>\n<p><strong>Mucosal neuromas</strong> can present with bumpy and enlarged lips, tongue, and eyelids. Intestinal autonomic ganglion dysfunction can lead to <strong>megacolon</strong> and diverticula. <strong>Medullated corneal fibers</strong> and delayed puberty can also be seen. <strong>Marfanoid habitus</strong> marked by tall stature, long limbs, arachnodactyly, and joint hypermobility is an associated feature.</p><hr><h3>Related Pearl: MEN 1 Syndrome Features</h3><p>Chromosome <strong>11q13 / MEN1 </strong>gene</p>\n<p>Also known as <strong>Wermer&rsquo;s syndrome</strong></p>\n<p>Characteristic tumors seen in:</p>\n<ul>\n<li>Parathyroid adenoma &ndash; 90 % - Most common overall</li>\n<li>Entero pancreatic tumors - Most common functioning tumor is gastrinoma (most common site is duodenum)</li>\n<li>Pituitary adenoma &ndash; Most common is prolactinoma</li>\n<li><strong>Mnemonic</strong> &ndash; Par Pan Pit &ndash; in decreasing order of frequency</li>\n</ul>\n<p>Associated tumors are:</p>\n<ul>\n<li>Angiofibroma</li>\n<li>Collagenomas</li>\n<li>Adrenal cortical tumors</li>\n<li>Lipoma</li>\n<li>Neuroendocrine tumors - gastric, thymic, lungs</li>\n<li>Meningioma</li>\n<li>Pheochromocytoma</li>\n<li>Carcinoid tumors, usually of the foregut</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/95f7c4eac7794f728806926c4f50bbb2x1280x1061.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: MEN 2 Syndrome Features</h3><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple&rsquo;s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10&ndash;25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40&ndash;50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: MEN 4 Syndrome Features</h3><p>It is associated with CDKN1B gene on&nbsp;chromosome 12.</p>\n<p>Associated conditions:</p>\n<ul>\n<li>Parathyroid adenoma</li>\n<li>Pituitary adenoma</li>\n<li>Reproductive organ tumors like testicular cancer, neuroendocrine cervical carcinoma</li>\n<li>Adrenal and renal tumors</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5347",
      "difficulty": "medium"
    },
    {
      "text": "A patient with coronary artery disease presents to you with chest pain and palpitations. The ECG is shown below. Which of the following can be used in the management?",
      "choices": [
        {
          "id": 1,
          "text": "Oral metoprolol"
        },
        {
          "id": 2,
          "text": "Oral amiodarone"
        },
        {
          "id": 3,
          "text": "Intravenous amiodarone"
        },
        {
          "id": 4,
          "text": "Intravenous metoprolol"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical scenario along with the ECG points to a diagnosis of&nbsp;<strong>ventricular tachycardia</strong>. <strong>Intravenous amiodarone</strong> (class III antiarrhythmic) can be used in the management of this condition.&nbsp;</p>\n<p>The patient here complaining of chest pain, and <strong>palpitations</strong> and has ECG changes showing <strong>wide QRS</strong> complex tachycardia with <strong>absent p</strong> <strong>waves</strong> is likely to have acute ventricular tachycardia. Since the patient is stable and has an underlying&nbsp;coronary artery disease the drug of choice is <strong>intravenous amiodarone</strong>.</p>\n<p>Ventricular tachycardias can be defined as three or more pre-ventricular contractions at a rate &gt;100/minute.</p>\n<p>ECG changes include wide<strong>&nbsp;QRS complexes,&nbsp;</strong><strong>absence of P waves</strong>, and ventriculoatrial dissociation.&nbsp;It can be broadly classified as <strong>sustained VT</strong> or <strong>non-sustained VT</strong>. Nonsustained VT has QRS complexes lasting&nbsp;<strong>&lt;30 seconds</strong> while sustained VT lasts for <strong>&gt;30 seconds</strong>. In monomorphic VT, all QRS complexes look the same. Polymorphic VT has QRS complexes varying in shape or direction in the same lead.&nbsp;</p>\n<p>Most monomorphic VT have an <strong>underlying cardiac disease</strong>. Symptoms of ventricular tachycardia include <strong>palpitations</strong>, syncope, and shortness of breath.&nbsp;</p>\n<p>In a hemodynamically <strong>stable</strong> patient, <strong>amiodarone</strong>, <strong>procainamide</strong>, and lidocaine can be used to treat the condition. In the <strong>presence</strong> of <strong>heart disease</strong>, intravenous<strong> amiodarone</strong> is the drug of choice. In hemodynamically <strong>unstable</strong> patients, <strong>electrical cardioversion</strong> is done. Further management depends on the underlying heart condition and frequency of VT. Frequent episodes warrant the use of antiarrhythmics or catheter ablation.&nbsp;</p>\n<p><strong>Torsades de Pointes</strong> is a type of polymorphic VT occurring with QT prolongation.&nbsp;It can progress to <strong>ventricular fibrillation</strong> which is treated with defibrillation. Recurrent episodes can be managed with <strong>intravenous magnesium sulfate</strong>.</p>\n<p>Other causes of wide QRS complexes include supraventricular tachycardias with bundle branch block and Wolff-Parkinson-White syndrome.&nbsp;</p>\n<p>Other options:</p>\n<p>Options A and D: <strong>Metoprolol</strong> is a <strong>selective&nbsp;&beta;1-antagonist </strong>and&nbsp;a<strong> class II antiarrhythmic</strong>. It can be used in hypertension, angina, and heart failure. The intravenous form can be used for initial management in acute myocardial infarction.</p>\n<p>Option B: <strong>Oral amiodarone</strong> can be used in the <strong>chronic treatment</strong> of atrial fibrillation, ventricular tachycardia, and ventricular fibrillation. It has shown a modest <strong>beneficial effect</strong> on<strong> mortality</strong> after acute myocardial infarction.</p><hr><h3>Related Pearl: ECG patterns of various ventricular arrhythmias</h3><p>Ventricular tachycardia</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/097b95729fa14ac68da475ce6288a968x1088x570.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Polymorphic ventricular tachycardia associated with QTc prolongation- Torsades de pointes</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a8ebe0b5757c4efca4f5dd15c6d24e99x1268x324.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Ventricular flutter</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/666962cd0f424000b7e84123f719f120x502x282.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>Ventricular fibrillation</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/25067efa869941baa6a40b54599b371ax1049x213.PNG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Etiology of Torsade De Pointes</h3><p><strong>Acquired prolongation of QT interval</strong></p>\n<p><strong>Electrolyte abnormalities</strong></p>\n<ul>\n<li>Hypokalemia</li>\n<li>Hypomagnesemia</li>\n<li>Hypocalcemia</li>\n</ul>\n<p><strong>Drugs</strong></p>\n<ul>\n<li><strong>Antiarrhythmic drugs</strong>\n<ul>\n<li>Class IA: Quinidine, disopyramide, procainamide</li>\n<li>Class III: Sotalol, amiodarone (QT prolongation common but torsade ventricular tachycardia is rare), ibutilide, dofetilide, almokalant</li>\n</ul>\n</li>\n<li><strong>Antibiotics</strong>\n<ul>\n<li>Macrolides: Erythromycin, clarithromycin, azithromycin</li>\n<li>Fluoroquinolones: Levofloxacin, moxifloxacin, gatifloxacin</li>\n<li>Trimethoprim-sulfamethoxazole</li>\n<li>Clindamycin</li>\n<li>Pentamidine</li>\n<li>Chloroquine</li>\n<li>Antifungals: Ketoconazole, itraconazole</li>\n<li>Antivirals</li>\n<li>Antipsychotics</li>\n<li>Antihistamines</li>\n</ul>\n</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/638ed288f9d54f7ebdb45b419dee35ee.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5408",
      "difficulty": "easy"
    },
    {
      "text": "Multidrug-resistant (MDR) tuberculosis shows resistance to which of the following drugs?",
      "choices": [
        {
          "id": 1,
          "text": "Isoniazid, rifampicin, and fluoroquinolone"
        },
        {
          "id": 2,
          "text": "Fluoroquinolones"
        },
        {
          "id": 3,
          "text": "Isoniazid and rifampicin"
        },
        {
          "id": 4,
          "text": "Isoniazid, rifampicin, and kanamycin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Muti-drug resistant</strong> (MDR) <strong>tuberculosis</strong> (TB) shows resistance to <strong>isoniazid</strong> and <strong>rifampicin</strong>.&nbsp;</p>\n<p>MDR-TB poses a serious problem in the treatment of TB as isoniazid and rifampicin are the most potent first-line drugs.&nbsp;</p>\n<p>The treatment of MDR-TB is curated with drugs grouped into different classes by the world health organization (WHO).</p>\n<ul>\n<li>Group A: Levofloxacin, bedaquiline, linezolid</li>\n<li>Group B: Clofazimine, cycloserine</li>\n<li>Group C: Ethambutol, pyrazinamide, delamanid, ethionamide</li>\n</ul>\n<p>In patients treated previously or with additional drug resistance, a <strong>longer MDR-TB regimen</strong> of <strong>18-20 months</strong> is recommended. Drugs belonging to group A are preferred along with one drug from group B whenever possible. A <strong>shorter regimen</strong> of <strong>6 months</strong> including <strong>bedaquiline</strong> with other drugs can be used in patients not treated before and without extensive disease. In <strong>pregnant women</strong> with MRD-TB, drugs such as bedaquiline and delamanid should be avoided.&nbsp;</p>\n<p>The nucleic acid amplification test (<strong>NAAT</strong>)/ <strong>gene Xpert</strong>&nbsp;is used to detect <strong>rpoB gene polymorphisms,</strong> which are responsible for rifampicin resistance.&nbsp;</p>\n<p>The four drugs considered first-line agents in the treatment of TB are isoniazid, rifampicin, pyrazinamide, and ethambutol.&nbsp;</p>\n<p><strong>Isoniazid</strong> is an antibiotic that works by inhibiting the synthesis of <strong>mycolic acid</strong>, an essential component of the mycobacterial cell wall. It is a <strong>bactericidal</strong> drug. It acts as a <strong>vitamin B6 antagonist</strong>, so oral <strong>pyridoxine</strong> supplementation is recommended during treatment. Side effects include peripheral neuritis, seizures, and ataxia.&nbsp;</p>\n<p><strong>Rifampicin</strong> is a macrocyclic antibiotic that <strong>inhibits RNA synthesis</strong> and is <strong>bactericidal</strong>. It is also used in the prophylaxis of meningococcal infections. Side effects include rash, vomiting, and hepatitis. It is a microsomal enzyme inducer that can result in <strong>contraceptive failure</strong>.&nbsp;</p>\n<p><strong>Ethambutol</strong> inhibits the mycobacterial cell wall assembly. Side effects include <strong>optic neuritis</strong>, pruritus, and joint pain.</p>\n<p><strong>Pyrazinamide</strong> is a nicotinamide analogue activated in acidic conditions. Side effects include liver injury and hyperuricemia.</p>\n<p>Other options: <strong>Fluoroquinolones</strong> are considered <strong>second-line agents</strong> used in the treatment for drug-resistant TB. <strong>Kanamycin</strong>, an<strong> injectable aminoglycoside</strong> is excluded from the new WHO classification of second-line drugs.&nbsp;</p><hr><h3>Related Pearl: ATT Regimen for TB Patients</h3><p>As per the latest recommendations from <strong>National Tuberculosis Elimination Programme (NTEP)</strong>, treatment of TB is now based primarily on <strong>drug susceptibility testing</strong>. This is irrespective of new cases, previously treated cases or recurrent TB cases. <br />All cases of TB are treated with Drug Sensitive TB Regimen, as long as the patient is sensitive to isoniazid and rifampicin. (<strong>No classification into category I or II</strong>)</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Type of TB Case</strong></td>\n<td><strong>Intensive Phase</strong></td>\n<td><strong>Continuation Phase</strong></td>\n</tr>\n<tr>\n<td>New and previously treated cases (H and R sensitive)</td>\n<td>2 months H R Z E</td>\n<td>4 months H R E</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2><strong><span>Classification based on drug resistance. </span></strong></h2>\n<p><span>The<strong> </strong>cases are classified as:</span></p>\n<ul>\n<li><strong>Mono-resistant (MR):</strong> A TB patient, who is resistant to one 1st line anti-TB drug only.</li>\n<li><strong>Poly-Drug Resistant (PDR):</strong> A TB patient, who is resistant to more than one 1st line anti-TB drug, other than Rifampicin and isoniazid. </li>\n<li><strong>Rifampicin Resistant (RR):</strong> A TB patient, who is resistant to <strong>rifampicin</strong> with or without resistance to other drugs. Patients, who have rifampicin resistance, should be managed as if they are an MDR TB case.</li>\n<li><strong>Multi-Drug Resistant (MDR):</strong> A TB patient, who is resistant to <strong>both isoniazid and rifampicin.</strong></li>\n<li><strong>Extensively Drug-Resistant (XDR):</strong> A MDR TB patient who is additionally resistant to a <strong>fluoroquinolone</strong> (ofloxacin, levofloxacin, or moxifloxacin) and at least one additional group A drug (as of 2021, these are bedaquiline and linezolid)</li>\n</ul>\n<h2><strong><span>Standard DR TB regimen</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Regimen class</strong></td>\n<td><strong>Drugs</strong></td>\n<td><strong>Comments</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/ poly-drug resistant TB regimen</strong></td>\n<td>Lfx R E Z for 6 months</td>\n<td>\n<p>6 months long</p>\n<p>Oral drugs only</p>\n</td>\n</tr>\n<tr>\n<td><strong>BPaLM regime (New MDR regime by WHO)</strong></td>\n<td>Bdq Pa Lzd Mfx for 6 months</td>\n<td>\n<p>6 months long</p>\n</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter oral bedaquiline regime (Shorter MDR)</strong></td>\n<td>\n<p><strong>Intensive Phase:</strong></p>\n<p>Lfx Bdq(6 months) Cfz Z Hh E Eto for 4-6 months</p>\n<p><strong>Continuation phase:</strong></p>\n<p>Lfx Cfz Z E for 5 months</p>\n</td>\n<td>\n<p>9-11 months long totally</p>\n<p>Injectables used in Intensive phase.</p>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Bdq(6 months or longer) Lfx Lzd Cfz Cs </td>\n<td>\n<p>18-20 months long</p>\n<p>Oral drugs only</p>\n<p>This regimen is used for XDR TB patients for 20 months.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<h2> </h2>\n<h2><strong><span>Criteria for patients to receive standard Drug Resistant TB regimen:</span></strong></h2>\n<table>\n<tbody>\n<tr>\n<td><strong>Standard Drug Resistant TB regimen</strong></td>\n<td><strong>Inclusion criteria</strong></td>\n<td><strong>Exclusion criteria</strong></td>\n</tr>\n<tr>\n<td><strong>H mono-resistant/poly-drug resistant TB regimen</strong></td>\n<td><strong>Isoniazid resistant</strong> TB with <strong>rifampicin sensitive</strong></td>\n<td>No specific criteria</td>\n</tr>\n<tr>\n<td><strong>BPaLM regimen (New MDR TB regimen by WHO)</strong></td>\n<td>\n<ol>\n<li><strong>MDR/RR-TB</strong> or <strong>pre-XDR-TB</strong> ( MDR/RR-TB and resistance to fluoroquinolones). </li>\n<li>Those with <strong>confirmed</strong> pulmonary TB and all forms of extrapulmonary TB (except for TB involving CNS, osteoarticular, and miliary TB).</li>\n<li>Patients <strong>&gt;14 years of age.<br /></strong></li>\n</ol>\n</td>\n<td>Pregnant and lactating women</td>\n</tr>\n<tr>\n<td><strong>9- 11 months shorter MDR TB regimen</strong></td>\n<td>Patient with <strong>rifampicin resistant</strong> pulmonary or extra pulmonary TB</td>\n<td>Non drug sensitivity test based criteria:\n<ul>\n<li>Pregnancy</li>\n<li>Any extra pulmonary disease in PLHIV</li>\n<li>Disseminated meningeal or central nervous system TB</li>\n<li>Intolerance to any drug in the shorter MDR TB regimen</li>\n</ul>\nDrug sensitivity test based criteria:\n<ul>\n<li>If DST/DRT result for FQ or SLI is resistant (XDR TB)</li>\n<li>Presence of InhA mutation</li>\n<li>Resistant to Z </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Longer MDR TB regimen</strong></td>\n<td>Patients in whom <strong>shorter MDR TB regimen cannot be considered</strong> due to any reason</td>\n<td>None</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Legend</p>\n<p>FQ: Fluoroquinolone</p>\n<p>SLI: Second Line Injectable</p>\n<p>PLHIV: People Living with HIV</p>\n<p>Lfx: Levofloxacin</p>\n<p>Pa: Pretomanid</p>\n<p>H: Isoniazid</p>\n<p>Hh: High Dose Isoniazid</p>\n<p>R: Rifampicin</p>\n<p>E: Ethambutol</p>\n<p>Z: Pyrazinamide</p>\n<p>Mfx: Moxifloxacin</p>\n<p>Km: Kanamycin</p>\n<p>Am: Amikacin</p>\n<p>Eto: Ethionamide</p>\n<p>Cfz: Clofazimine</p>\n<p>Bdq: Bedaquiline</p>\n<p>Lzd: Linezolid</p>\n<p>Cs: Cycloserine</p><hr><h3>Related Pearl: General properties of the first line drugs in TB</h3><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>First-line drugs</strong></span></div>\n</td>\n<td>\n<div><span><strong>Isoniazid</strong></span></div>\n</td>\n<td>\n<div><span><strong>Rifampicin</strong></span></div>\n</td>\n<td>\n<div><span><strong>Pyrazinamide</strong></span></div>\n</td>\n<td>\n<div><span><strong>Ethambutol</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Mechanism</strong></span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n<div><span>(Maximum)</span></div>\n</td>\n<td>\n<div><span>Bactericidal</span></div>\n</td>\n<td>\n<div><span>Bacteriostatic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Location of Mycobacteria</strong></span></div>\n</td>\n<td>\n<div><span>Intracellular +&nbsp; Extracellular</span></div>\n</td>\n<td>\n<div><span>Intracellular +&nbsp; Extracellular</span></div>\n</td>\n<td>\n<div><span>Intracellular</span></div>\n</td>\n<td>\n<div><span>Extracellular</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Metabolism</strong></span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n<div><span>(Maximum)</span></div>\n</td>\n<td>\n<div><span>Liver</span></div>\n</td>\n<td>\n<div><span>Kidney</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5401",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents to you with fever, jaundice, and malaise. What is the most likely diagnosis based on the serology reports given below?<div class='question-desc-html'><p>Anti-HBc (IgM): Positive</p>\n<p>HBsAg: Positive</p>\n<p>Anti-HBs: Negative</p>\n<p>Anti-HCV antibodies: Negative</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Acute hepatitis B"
        },
        {
          "id": 2,
          "text": "Acute hepatitis C"
        },
        {
          "id": 3,
          "text": "Chronic hepatitis B"
        },
        {
          "id": 4,
          "text": "Chronic hepatitis C"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario along with the serology reports suggest a diagnosis of <strong>acute hepatitis B</strong>.</p>\n<p>Acute hepatitis B presents after an incubation period of 30-180 days with symptoms such as anorexia, <strong>malaise</strong>, and myalgias. A low-grade <strong>fever</strong> can also be associated. These symptoms can precede <strong>jaundice</strong> by 1-2 weeks. Mild weight loss and <strong>tender hepatomegaly</strong> are other features.</p>\n<p>The <strong>presence</strong> of <strong>HBsAg</strong> (hepatitis B surface antigen), also known as <strong>Australia antigen</strong>,&nbsp;<strong>IgM anti-HBc</strong> antibodies (antibodies against hepatitis B core antigen), and the&nbsp;<strong>absence</strong> of <strong>anti-HBs</strong> is the characteristic picture seen in acute hepatitis B with <strong>high infectivity</strong>. The absence of anti-HCV antibodies excludes a diagnosis of hepatitis C.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d4539aecc8904be39eb8406cef1171d5x1280x1156.JPEG\" alt=\"Explanation Image\"><p><strong>Aspartate transaminase</strong> (AST) and <strong>alanine transaminase</strong> (ALT) values are usually elevated along with bilirubin levels. Serological markers vary according to the phase of the disease process as shown below.</p>\n<p>Most cases undergo spontaneous recovery. Prophylaxis can be carried out with the use of <strong>vaccines</strong> containing <strong>HbsAg</strong>. <strong>Anti-HBs titres&nbsp;&ge; 10mIU/mL</strong> are protective.&nbsp;</p>\n<p>Acute viral hepatitis can be due to due to any of the five agents - hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV), and hepatitis E virus (HEV).&nbsp;Clinical features of all acute viral hepatitis are similar. A patient suspected to have acute hepatitis should be tested for HBsAg, <strong>IgM anti-HAV</strong>, IgM anti-HBc, and anti-HCV.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Acute hepatitis C</strong> is caused by HCV which is an RNA virus. It is a blood-borne infection. Detection of <strong>anti-HCV</strong> and <strong>HCV RNA</strong> is used for diagnosis. HCV-RNA appears before anti-HCV and persists for the entire duration of the disease.</p>\n<p>Option C: <strong>Chronic hepatitis B</strong> is a late complication of acute hepatitis B. Persistence of HBeAg for &gt;3 months or HBsAg for &gt;6 months is suggestive of the development of the condition. Investigations show the presence of HBsAg, IgG anti-HBc, HBeAg, and HBV DNA. Fatigue and <strong>intermittent jaundice</strong> are the main features. It can progress to<strong> cirrhosis</strong> or <strong>hepatocellular carcinoma</strong>. <strong>Hepatitis D superinfection</strong> can accelerate this progression.</p>\n<p>Option D:<strong> Chronic hepatitis C</strong> is a common complication of acute hepatitis C. It can progress to cirrhosis or hepatocellular carcinoma HCV-RNA and anti-HCV can be detected on serology.&nbsp;</p><hr><h3>Related Pearl: Acute Hepatitis vs. Chronic Hepatitis</h3><table>\n<tbody>\n<tr>\n<td><strong>Histological features of acute hepatitis</strong></td>\n<td><strong>Histological features of chronic hepatitis</strong></td>\n</tr>\n<tr>\n<td>Ballooning degeneration</td>\n<td>Ductular reaction</td>\n</tr>\n<tr>\n<td>Apoptosis of hepatocytes - <strong>Councilman bodies </strong></td>\n<td>Bridging fibrosis </td>\n</tr>\n<tr>\n<td>Confluent necrosis</td>\n<td>Bridging necrosis</td>\n</tr>\n<tr>\n<td>Spotty necrosis or lobular<strong> hepatitis </strong></td>\n<td>Interface hepatitis </td>\n</tr>\n<tr>\n<td>Bridging necrosis in severe acute hepatitis</td>\n<td>Dense, mononuclear portal infiltration </td>\n</tr>\n<tr>\n<td>Portal inflammation is absent </td>\n<td><strong>Chronic viral hepatitis</strong></td>\n</tr>\n<tr>\n<td> </td>\n<td>Ground glass hepatocytes </td>\n</tr>\n<tr>\n<td> </td>\n<td>Lymphoid aggregates or fully formed lymphoid follicles</td>\n</tr>\n<tr>\n<td> </td>\n<td>Fatty change of scattered hepatocytes</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ed3b8d201aea404fbad0181756978b57x1280x3480.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: The most commons in hepatitis</h3><table>\n<tbody>\n<tr>\n<td><strong>CAUSE</strong></td>\n<td><strong>ETIOLOGICAL AGENT</strong></td>\n</tr>\n<tr>\n<td>Most common cause of viral hepatitis</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis in children</td>\n<td>HepA</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis in adults</td>\n<td>HepE</td>\n</tr>\n<tr>\n<td>Most common cause of viral hepatitis in pregnancy</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis related mortality in pregnancy</td>\n<td>HepE</td>\n</tr>\n<tr>\n<td>Most common cause of acute liver failure (Western countries)</td>\n<td>Paracetamol poisoning</td>\n</tr>\n<tr>\n<td>Most common cause of acute liver failure in India</td>\n<td> Viral hepatitis (B and E)</td>\n</tr>\n<tr>\n<td>Most common cause of viral fulminant hepatitis</td>\n<td> HepE</td>\n</tr>\n<tr>\n<td>Highest risk of progresion from acute viral hepatitis to fulminant hepatitis</td>\n<td>HepD </td>\n</tr>\n<tr>\n<td>Most common cause of chronic hepatitis (prevalence)</td>\n<td>HepB (450 million)</td>\n</tr>\n<tr>\n<td>Most common cause of acute viral hepatitis, leading to chronic<br />hepatitis (prevalence)</td>\n<td> HepC (150 million)</td>\n</tr>\n<tr>\n<td>Maximum risk and max potential of chronicity</td>\n<td>HepC</td>\n</tr>\n<tr>\n<td>Most common cause of carrier State</td>\n<td>HepB</td>\n</tr>\n<tr>\n<td>Most common cause of cirrhosis</td>\n<td>Alcohol</td>\n</tr>\n<tr>\n<td>Most common viral cause of cirrhosis</td>\n<td>HepC</td>\n</tr>\n<tr>\n<td>Most common cause of viral hepatocellular carcinoma</td>\n<td>HepB</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Interpretation of common serologic patterns in hepatitis B infection</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5552cae694994040b6b13be6442fc5adx1280x1466.JPEG\" alt=\"Pearl Image\"><p> </p>\n<table>\n<tbody>\n<tr>\n<td> <strong>Clinical Phases</strong></td>\n<td><span><strong>HBsAg</strong></span></td>\n<td><span><strong>Anti-HBs</strong></span></td>\n<td><span><strong>HBeAg</strong></span></td>\n<td><span><strong>Anti-HBe</strong></span></td>\n<td><span><strong>Anti-HBc</strong></span></td>\n<td><span><strong>HBV DNA</strong></span></td>\n</tr>\n<tr>\n<td><span>Acute HBV - Early-phase, high infectivity</span></td>\n<td>\n<p><span>+</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgM</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV -</span><span>Window phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgM</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Acute HBV - recovery phase</span></p>\n</td>\n<td>\n<p><span>-</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>+/-</span></td>\n</tr>\n<tr>\n<td><span>Chronic HBV, high infectivity</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>+++</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Chronic HBV, low infectivity</span></p>\n</td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>IgG</span></td>\n<td><span>+</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the recent past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>HBV infection in the remote past</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>+/-</span></td>\n<td><span>IgG</span></td>\n<td><span>-</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Post-vaccination</span></p>\n</td>\n<td><span>-</span></td>\n<td><span>+</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n<td><span>-</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5421",
      "difficulty": "easy"
    },
    {
      "text": "A child presents to the emergency department with a  history of ingestion of 10-20 ferrous sulfate tablets.  Arterial blood gas revealed acidosis. Which of the following can be used in the management of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Deferoxamine"
        },
        {
          "id": 2,
          "text": "Activated charcoal"
        },
        {
          "id": 3,
          "text": "Dimercaprol"
        },
        {
          "id": 4,
          "text": "Penicillamine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical scenario points to <strong>iron toxicity</strong>, which is managed with <strong>deferoxamine</strong> (also known as&nbsp;<strong>desferrioxamine</strong>).</p>\n<p>Large amounts of ferrous salts can be fatal in <strong>children</strong>. Initial symptoms include <strong>abdominal pain</strong>, diarrhea, vomiting, and <strong>gastrointestinal bleeding</strong>. In severe cases, <strong>cyanosis</strong> and hyperventilation due to <strong>acidosis</strong> can develop. This can sometimes be followed by an <strong>asymptomatic phase</strong>. Later, hypoglycemia and hepatic and renal failure can develop. <strong>Pyloric stenosis</strong> and gastric scarring can develop due to its corrosive nature. Ultimately, if left untreated, the child can die.</p>\n<p>The gastric contents can be used for an iron color test to estimate the iron concentration in plasma. As iron tablets are <strong>radiopaque</strong>, an X-ray can be used to assess the number of pills taken. <strong>Deferoxamine</strong>, an <strong>iron chelator</strong> has to be administered <strong>intramuscularly</strong>. Side effects include pruritus, wheals, rash, and anaphylaxis.&nbsp;</p>\n<p><strong>Deferiprone</strong> and <strong>deferasirox</strong> are other <strong>oral</strong> iron chelators used to treat iron overload in<strong> thalassemia</strong> patients.&nbsp;</p>\n<p>Other options:</p>\n<p>Option B: <strong>Activated charcoal</strong> can be used in the initial management of acetaminophen and opioid overdose. It is used for gastrointestinal decontamination to prevent further absorption of the poison.</p>\n<p>Option C: <strong>Dimercaprol,</strong>&nbsp;also known as <strong>BAL</strong> (British anti-Lewisite), is used to treat <strong>arsenic</strong>, mercury poisoning, and <strong>Wilson's disease</strong>.</p>\n<p>Option D: <strong>D-penicillamine</strong> (Cuprimine) can be used to treat scleroderma, <strong>Wilson's disease</strong>, and rheumatoid arthritis. Side effects include nephrotoxicity, hematologic derangements, and a characteristic rash that involves the neck and axillae&mdash;<strong>elastosis perforans serpiginosa</strong>.&nbsp;It is associated with membranous glomerulonephritis, drug-induced lupus, and <strong>myasthenia gravis</strong>.</p><hr><h3>Related Pearl: Specific antidotes for poisoning</h3><table>\n<tbody>\n<tr>\n<td><strong>ANTIDOTE</strong></td>\n<td><strong>POISONING</strong></td>\n</tr>\n<tr>\n<td><strong>4-methyl pyrazole</strong></td>\n<td>Methanol and ethylene glycol</td>\n</tr>\n<tr>\n<td><strong>100% oxygen </strong></td>\n<td>Carbon monoxide, cyanide, methemoglobinemia</td>\n</tr>\n<tr>\n<td><strong>Ammonium chloride </strong></td>\n<td>Phencyclidine, amphetamine</td>\n</tr>\n<tr>\n<td><strong>Amyl nitrate </strong></td>\n<td>Cyanide, hydrogen sulphide</td>\n</tr>\n<tr>\n<td><strong>Atropine</strong></td>\n<td>Carbamate and organophosphorus poisoning</td>\n</tr>\n<tr>\n<td><strong>Bupropion</strong></td>\n<td>Nicotine</td>\n</tr>\n<tr>\n<td><strong>Calcium disodium edetate</strong></td>\n<td>Cadmium, chromium, cobalt, copper, lead, magnesium, nickel, uranium, zinc</td>\n</tr>\n<tr>\n<td><strong>Calcium gluconate </strong></td>\n<td>Precipitates fluorides, magnesium and oxalates</td>\n</tr>\n<tr>\n<td><strong>Chlorpromazine</strong></td>\n<td>Amphetamine</td>\n</tr>\n<tr>\n<td><strong>Deferoxamine</strong></td>\n<td>Iron, aluminium</td>\n</tr>\n<tr>\n<td><strong>Diazepam</strong></td>\n<td>Amphetamine, chloroquine, alcohol withdrawal</td>\n</tr>\n<tr>\n<td><strong>Dicobalt edetate</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Dimercaprol (BAL)</strong></td>\n<td>Antimony, arsenic, copper, lead, mercury, nickel and gold</td>\n</tr>\n<tr>\n<td><strong>Diphenhydramine</strong></td>\n<td>Phenothiazines and related drugs</td>\n</tr>\n<tr>\n<td><strong>Disodium calcium edetate</strong></td>\n<td><strong>&nbsp;</strong>Lead</td>\n</tr>\n<tr>\n<td><strong>DMPS *, (Unithiol)</strong></td>\n<td><strong>&nbsp;</strong>Mercury</td>\n</tr>\n<tr>\n<td><strong>DMSA ** </strong></td>\n<td><strong>&nbsp;</strong>Lead</td>\n</tr>\n<tr>\n<td><strong>D-Penicillamine (Cuprimine) </strong></td>\n<td>Copper, lead, mercury, chromate, nickel, zinc, arsenic</td>\n</tr>\n<tr>\n<td><strong>Ethanol</strong></td>\n<td>Methanol and ethylene glycol</td>\n</tr>\n<tr>\n<td><strong>Fab fragment</strong></td>\n<td>Digoxin, digitoxin, oleander tea</td>\n</tr>\n<tr>\n<td><strong>Flumazenil</strong></td>\n<td>Benzodiazepine</td>\n</tr>\n<tr>\n<td><strong>Glucagon</strong></td>\n<td>Propranolol and other beta-blockers toxicity</td>\n</tr>\n<tr>\n<td><strong>Hydroxocobalamin</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Labetalol hydrochloride</strong></td>\n<td>Hypertensive crisis due to cocaine</td>\n</tr>\n<tr>\n<td><strong>Methionine</strong></td>\n<td>Paracetamol</td>\n</tr>\n<tr>\n<td><strong>Methylene blue</strong></td>\n<td>Methemoglobinemia</td>\n</tr>\n<tr>\n<td><strong>N-acetylcysteine </strong></td>\n<td>Paracetamol, acetaminophen toxicity</td>\n</tr>\n<tr>\n<td><strong>Nalorphine</strong></td>\n<td>Morphine</td>\n</tr>\n<tr>\n<td><strong>Naloxone (Naltrexone)</strong></td>\n<td>Narcotic, opiates, CNS depressants</td>\n</tr>\n<tr>\n<td><strong>Nicotinamide</strong></td>\n<td>Vacor poisoning, phenylurea pesticide toxicity</td>\n</tr>\n<tr>\n<td><strong>Pancuronium bromide</strong></td>\n<td>Neuromuscular blocking agents</td>\n</tr>\n<tr>\n<td><strong>Penicillamine</strong></td>\n<td>Copper</td>\n</tr>\n<tr>\n<td><strong>Physostigmine salicylate </strong></td>\n<td>Coma, convulsions from anticholinergics</td>\n</tr>\n<tr>\n<td><strong>Pralidoxime (2-PAM) </strong></td>\n<td>Organophosphorus insecticides, nerve agents</td>\n</tr>\n<tr>\n<td><strong>Propranolol</strong></td>\n<td>Cocaine intoxication, beta adrenergics</td>\n</tr>\n<tr>\n<td><strong>Protamine sulphate </strong></td>\n<td>Heparin overdose</td>\n</tr>\n<tr>\n<td><strong>Prussian blue</strong></td>\n<td>Thallium</td>\n</tr>\n<tr>\n<td><strong>Pyridoxine (Vit. B6) </strong></td>\n<td>Isoniazid, hydrazine toxicity</td>\n</tr>\n<tr>\n<td><strong>Sodium bicarbonate </strong></td>\n<td>Urinary alkalinisation for salicylates, phenobarbital</td>\n</tr>\n<tr>\n<td><strong>Sodium nitrite</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Sodium thiosulphate</strong></td>\n<td>Cyanide</td>\n</tr>\n<tr>\n<td><strong>Vitamin K</strong></td>\n<td>Warfarin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Poisoning - Modalities of General Management</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;Management</td>\n<td>Examples</td>\n</tr>\n<tr>\n<td>Gastrointestinal decontamination</td>\n<td>\n<p>Orogastric Lavage</p>\n<p>Activated Charcoal</p>\n<p>Whole Bowel Irrigation</p>\n</td>\n</tr>\n<tr>\n<td>Enhanced elimination</td>\n<td>\n<p>Multidose activated charcoal</p>\n<p>Urinary alkalinization</p>\n<p>Extracorporeal removal(Hemodialysis, Hemoperfusion)</p>\n</td>\n</tr>\n<tr>\n<td>Administration of antidote</td>\n<td>\n<p>Mechanical Antidotes</p>\n<p>Chemical Antidotes</p>\n<p>Physiological Antidotes</p>\n<p>Pharmacological Antidotes</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Arsenic poisoning</h3><p>Summary of Arsenic poisoning</p>\n<p><strong>Source of exposure</strong>:&nbsp;Arsenic-containing pesticides, natural sources - drinking water and soil</p>\n<p><strong>Route of absorption</strong>:&nbsp;GI tract</p>\n<p><strong>Mechanism of action</strong>:&nbsp;binds to sulfhydryl groups and inhibits pyruvate dehydrogenase, gluconeogenesis, glutathione metabolism</p>\n<p>Characteristic clinical findings are as follows: Mnemonic-ARSENIC</p>\n<p><strong>A-&nbsp;</strong>Aldrich mees lines</p>\n<p><strong>R-&nbsp;</strong>raindrop pigmentation, rash,&nbsp;red velvety mucosa</p>\n<p><strong>S-&nbsp;</strong>subendocardial haemorrhage</p>\n<p><strong>E-&nbsp;</strong>Excessive pigmentation- Blackfoot&nbsp;disease</p>\n<p><strong>N-&nbsp;</strong>Neuritis</p>\n<p><strong>I-&nbsp;</strong>Iron oxide + BAL &ndash;treatment</p>\n<p><strong>C-&nbsp;</strong>Cholera like illness</p>\n<p><strong>Diagnosis</strong>:&nbsp;24-hour urine arsenic</p>\n<p><strong>Treatment</strong>:&nbsp;BAL; succimer(DMSA)</p>\n<p>Clinicopathological findings in acute and chronic arsenic poisoning:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>System</strong></p>\n</td>\n<td>\n<p><strong>Acute</strong></p>\n</td>\n<td>\n<p><strong>Chronic</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Delayed hair loss (alopecia)</p>\n</td>\n<td>\n<p>Melanosis, Bowen&rsquo;s disease facial edema, hyperkeratosis, cutaneous cancer, hyperpigmentation.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nails</p>\n</td>\n<td>\n<p>Mees&rsquo;s lines in 2-3 weeks post ingestion.</p>\n</td>\n<td>\n<p><strong>Mees' lines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neurologic</p>\n</td>\n<td>\n<p>Hyperpyrexia, convulsions, tremors, coma</p>\n</td>\n<td>\n<p>Encephalopathy, polyneuropathy, tremors, axonal degeneration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI tract</p>\n</td>\n<td>\n<p>Abdominal pain, dysphagia, vomiting, bloody or rice water diarrhea, mucosal erosions.</p>\n</td>\n<td>\n<p>Nausea, vomiting, diarrhea, anorexia, weight loss</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver</p>\n</td>\n<td>\n<p>Fatty infiltration</p>\n</td>\n<td>\n<p>Hepatomegaly, jaundice, cirrhosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidney</p>\n</td>\n<td>\n<p>Tubular and glomerular changes &ndash; oliguria and uremia</p>\n</td>\n<td>\n<p>Nephritic finding</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemetologic</p>\n</td>\n<td>\n<p>thrombocytopenia, impaired folate metabolism</p>\n</td>\n<td>\n<p>Bone marrow hypoplasia, anemia, leukopenia, basophilic stippling, and karyorrhexis.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiovascular</p>\n</td>\n<td>\n<ul>\n<li>S-T wave abnormalities,</li>\n<li>prolonged QT interval</li>\n<li>ventricular fibrillation</li>\n<li>atypical ventricular tachycardia&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>There is platelet activation and hypercoagulability of blood in peripheral arteries leading to blackfoot disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reproductive system</p>\n</td>\n<td>\n<p>Maternal ingestion of inorganic</p>\n<p>Arsenic crosses the placental barrier and infant death shortly after birth.</p>\n</td>\n<td>\n<p>-Nil-</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF5392",
      "difficulty": "easy"
    }
  ]
}